| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 4.77e-13 | 37 | 69 | 8 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 6.02e-13 | 38 | 69 | 8 | GO:0070001 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | NCOA2 KMT2D MRTFB MED12L SMARCA2 HIPK2 SMARCA4 ARID1A TRIM24 CREBBP MAML3 EP300 | 4.89e-10 | 303 | 69 | 12 | GO:0003713 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | NCOA2 YTHDF1 KMT2D MRTFB UBQLN2 RBM33 MED12L SMARCA2 HIPK2 SMARCA4 SYN1 ARID1A TRIM24 CREBBP CAPRIN1 MAML3 EP300 YTHDF2 RCOR2 NCOA5 | 1.23e-09 | 1160 | 69 | 20 | GO:0030674 |
| GeneOntologyMolecularFunction | transcription coregulator activity | NCOA2 KMT2D MRTFB MED12L SMARCA2 HIPK2 SMARCA4 ARID1A TRIM24 CREBBP MAML3 EP300 RCOR2 NCOA5 | 6.21e-09 | 562 | 69 | 14 | GO:0003712 |
| GeneOntologyMolecularFunction | molecular adaptor activity | NCOA2 YTHDF1 KMT2D MRTFB UBQLN2 RBM33 MED12L SMARCA2 HIPK2 SMARCA4 SYN1 ARID1A TRIM24 CREBBP CAPRIN1 MAML3 EP300 YTHDF2 RCOR2 NCOA5 | 1.76e-08 | 1356 | 69 | 20 | GO:0060090 |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 4.23e-08 | 11 | 69 | 4 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 1.27e-07 | 14 | 69 | 4 | GO:0003964 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 7.47e-07 | 21 | 69 | 4 | GO:0035613 | |
| GeneOntologyMolecularFunction | chromatin binding | NCOA2 PYGO2 BCAS3 SMARCA2 SMARCA4 CHD7 RUNX2 ARID1A TRIM24 CLOCK CREBBP EP300 NCOA5 | 1.25e-06 | 739 | 69 | 13 | GO:0003682 |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 3.31e-06 | 262 | 69 | 8 | GO:0140097 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 3.73e-06 | 187 | 69 | 7 | GO:0016922 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 7.86e-06 | 79 | 69 | 5 | GO:0004521 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 7.91e-06 | 37 | 69 | 4 | GO:0016891 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 7.91e-06 | 37 | 69 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 8.82e-06 | 38 | 69 | 4 | GO:0034061 | |
| GeneOntologyMolecularFunction | transcription factor binding | NCOA2 LATS1 BCAS3 MED12L HIPK2 SMARCA4 RUNX2 ARID1A TRIM24 CLOCK CREBBP EP300 | 9.27e-06 | 753 | 69 | 12 | GO:0008134 |
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 1.18e-05 | 2 | 69 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 1.18e-05 | 2 | 69 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 1.30e-05 | 417 | 69 | 9 | GO:0061629 | |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-6 USP9X ERVK-8 ERVK-19 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-24 | 1.65e-05 | 430 | 69 | 9 | GO:0004175 |
| GeneOntologyMolecularFunction | N6-methyladenosine-containing RNA reader activity | 1.74e-05 | 15 | 69 | 3 | GO:1990247 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 1.91e-05 | 46 | 69 | 4 | GO:0016893 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | NCOA2 LATS1 BCAS3 HIPK2 SMARCA4 RUNX2 ARID1A TRIM24 CREBBP EP300 | 2.97e-05 | 582 | 69 | 10 | GO:0140297 |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 3.52e-05 | 3 | 69 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | histone binding | 3.58e-05 | 265 | 69 | 7 | GO:0042393 | |
| GeneOntologyMolecularFunction | zinc ion binding | ERVK-6 ERVK-8 CIZ1 ERVK-19 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-24 TRIM24 CREBBP EP300 | 4.88e-05 | 891 | 69 | 12 | GO:0008270 |
| GeneOntologyMolecularFunction | protein-RNA adaptor activity | 7.59e-05 | 24 | 69 | 3 | GO:0140517 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 7.82e-05 | 206 | 69 | 6 | GO:0140030 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 1.08e-04 | 136 | 69 | 5 | GO:0004540 | |
| GeneOntologyMolecularFunction | endonuclease activity | 1.08e-04 | 136 | 69 | 5 | GO:0004519 | |
| GeneOntologyMolecularFunction | p53 binding | 1.46e-04 | 77 | 69 | 4 | GO:0002039 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 1.66e-04 | 31 | 69 | 3 | GO:0140033 | |
| GeneOntologyMolecularFunction | SMAD binding | 2.24e-04 | 86 | 69 | 4 | GO:0046332 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 2.81e-04 | 167 | 69 | 5 | GO:0031490 | |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 2.82e-04 | 37 | 69 | 3 | GO:0043425 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | ERVK-6 ERN1 ERVK-8 SMARCA2 SMARCA4 CHD7 ERVK-7 ERVK-10 ARID1A | 3.64e-04 | 645 | 69 | 9 | GO:0140640 |
| GeneOntologyMolecularFunction | peptidase activity | ERVK-6 USP9X ERVK-8 ERVK-19 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-24 | 4.03e-04 | 654 | 69 | 9 | GO:0008233 |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 4.30e-04 | 102 | 69 | 4 | GO:0016410 | |
| GeneOntologyMolecularFunction | transition metal ion binding | ERVK-6 ERVK-8 CIZ1 ERVK-19 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-24 TRIM24 CREBBP EP300 | 7.06e-04 | 1189 | 69 | 12 | GO:0046914 |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 7.30e-04 | 51 | 69 | 3 | GO:0004402 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 9.11e-04 | 55 | 69 | 3 | GO:0061733 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 9.80e-04 | 127 | 69 | 4 | GO:0008094 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 1.17e-03 | 60 | 69 | 3 | GO:0034212 | |
| GeneOntologyMolecularFunction | histone modifying activity | 1.18e-03 | 229 | 69 | 5 | GO:0140993 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 1.18e-03 | 229 | 69 | 5 | GO:0003714 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 1.20e-03 | 15 | 69 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | nuclease activity | 1.22e-03 | 231 | 69 | 5 | GO:0004518 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | AURKA ERVK-6 LATS1 ERN1 BUB1B ERVK-8 HIPK2 ERVK-7 ERVK-10 TRIM24 | 1.37e-03 | 938 | 69 | 10 | GO:0016772 |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 1.90e-03 | 152 | 69 | 4 | GO:0016779 | |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 2.15e-03 | 20 | 69 | 2 | GO:0035259 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 2.37e-03 | 21 | 69 | 2 | GO:0042975 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 2.50e-03 | 78 | 69 | 3 | GO:0008080 | |
| GeneOntologyMolecularFunction | DNA polymerase binding | 2.84e-03 | 23 | 69 | 2 | GO:0070182 | |
| GeneOntologyMolecularFunction | mRNA 3'-UTR AU-rich region binding | 4.50e-03 | 29 | 69 | 2 | GO:0035925 | |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 4.81e-03 | 30 | 69 | 2 | GO:0070577 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 5.61e-03 | 104 | 69 | 3 | GO:0016407 | |
| GeneOntologyMolecularFunction | nuclear androgen receptor binding | 5.80e-03 | 33 | 69 | 2 | GO:0050681 | |
| GeneOntologyMolecularFunction | lncRNA binding | 6.51e-03 | 35 | 69 | 2 | GO:0106222 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 8.39e-03 | 363 | 69 | 5 | GO:0106310 | |
| GeneOntologyMolecularFunction | molecular condensate scaffold activity | 9.27e-03 | 42 | 69 | 2 | GO:0140693 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 9.29e-03 | 238 | 69 | 4 | GO:0016747 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | FOXJ2 NCOA2 EBF3 SMARCA4 POU2F2 CHD7 RUNX2 TRIM24 CLOCK EP300 | 1.01e-02 | 1244 | 69 | 10 | GO:0000978 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | FOXJ2 NCOA2 EBF3 SMARCA4 POU2F2 CHD7 RUNX2 TRIM24 CLOCK CREBBP EP300 | 1.10e-02 | 1459 | 69 | 11 | GO:0000977 |
| GeneOntologyMolecularFunction | structural molecule activity | 1.15e-02 | 891 | 69 | 8 | GO:0005198 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | FOXJ2 NCOA2 EBF3 SMARCA4 POU2F2 CHD7 RUNX2 TRIM24 CLOCK EP300 | 1.16e-02 | 1271 | 69 | 10 | GO:0000987 |
| GeneOntologyMolecularFunction | ADP binding | 1.20e-02 | 48 | 69 | 2 | GO:0043531 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 1.26e-02 | 140 | 69 | 3 | GO:0001221 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 1.28e-02 | 560 | 69 | 6 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 1.34e-02 | 566 | 69 | 6 | GO:0001216 | |
| GeneOntologyMolecularFunction | nuclear estrogen receptor binding | 1.45e-02 | 53 | 69 | 2 | GO:0030331 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | 1.46e-02 | 417 | 69 | 5 | GO:0140098 | |
| GeneOntologyBiologicalProcess | DNA integration | 8.01e-08 | 13 | 69 | 4 | GO:0015074 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 3.56e-07 | 136 | 69 | 7 | GO:0030518 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 3.69e-07 | 202 | 69 | 8 | GO:0141193 | |
| GeneOntologyBiologicalProcess | viral process | ERVK-6 ERVK-8 SMARCA4 ERVK-19 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-24 CREBBP EP300 | 3.74e-07 | 464 | 69 | 11 | GO:0016032 |
| GeneOntologyBiologicalProcess | regulation of intracellular steroid hormone receptor signaling pathway | 4.58e-07 | 87 | 69 | 6 | GO:0033143 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | FOXJ2 NCOA2 KMT2D MRTFB EBF3 BCAS3 MED12L SMARCA2 HIPK2 SMARCA4 POU2F2 CHD7 RUNX2 CLOCK CREBBP MAML3 EP300 PYGO1 | 4.67e-07 | 1390 | 69 | 18 | GO:0045944 |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 8.63e-07 | 155 | 69 | 7 | GO:0043401 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | FZD1 FOXJ2 CACNA1A ERVK-6 LATS1 BCAS3 ENAH ERVK-8 HIPK2 SMARCA4 ROBO2 ERVK-19 ERVK-21 ERVK-9 ARID1A SDK1 EP300 EPN2 | 1.20e-06 | 1483 | 69 | 18 | GO:0048646 |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 1.54e-06 | 244 | 69 | 8 | GO:0009755 | |
| GeneOntologyBiologicalProcess | stress granule assembly | 6.23e-06 | 36 | 69 | 4 | GO:0034063 | |
| GeneOntologyBiologicalProcess | synapse assembly | 8.56e-06 | 308 | 69 | 8 | GO:0007416 | |
| GeneOntologyBiologicalProcess | cell-cell fusion | 9.64e-06 | 85 | 69 | 5 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 9.64e-06 | 85 | 69 | 5 | GO:0000768 | |
| GeneOntologyBiologicalProcess | syncytium formation | 1.21e-05 | 89 | 69 | 5 | GO:0006949 | |
| GeneOntologyBiologicalProcess | DNA damage response | ERVK-6 MYO6 USP9X ERVK-8 SMARCA2 HIPK2 SMARCA4 ERVK-7 ERVK-10 ARID1A CLOCK CREBBP EP300 | 1.50e-05 | 959 | 69 | 13 | GO:0006974 |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 1.50e-05 | 239 | 69 | 7 | GO:0071383 | |
| GeneOntologyBiologicalProcess | embryo development | FZD1 KMT2D MRTFB LATS1 MYO6 USP9X ENAH HIPK2 SMARCA4 CHD7 RUNX2 ARID1A CREBBP EP300 YTHDF2 EPN2 | 1.59e-05 | 1437 | 69 | 16 | GO:0009790 |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 2.00e-05 | 48 | 69 | 4 | GO:0000731 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | FZD1 LATS1 MYO6 ENAH HIPK2 SMARCA4 CHD7 RUNX2 ARID1A CREBBP YTHDF2 | 2.29e-05 | 713 | 69 | 11 | GO:0048598 |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated glucocorticoid signaling pathway | 2.36e-05 | 17 | 69 | 3 | GO:0042921 | |
| GeneOntologyBiologicalProcess | cellular response to hormone stimulus | NCOA2 KMT2D LATS1 BCAS3 SMARCA4 GRIA1 ARID1A TRIM24 CLOCK EP300 NCOA5 | 2.74e-05 | 727 | 69 | 11 | GO:0032870 |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated corticosteroid signaling pathway | 2.82e-05 | 18 | 69 | 3 | GO:0031958 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | FZD1 KMT2D MRTFB LATS1 USP9X ENAH SMARCA4 CHD7 RUNX2 ARID1A EP300 EPN2 | 4.19e-05 | 906 | 69 | 12 | GO:0043009 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | FZD1 NCOA2 MAGEL2 USP9X SMARCA2 HIPK2 SMARCA4 RUNX2 ARID1A TRIM24 CLOCK CREBBP EP300 RCOR2 NCOA5 | 4.78e-05 | 1399 | 69 | 15 | GO:0045892 |
| GeneOntologyBiologicalProcess | head development | FZD1 CACNA1A MRTFB PYGO2 USP9X SMARCA4 GRIA1 ROBO2 CHD7 ARID1A CREBBP EP300 | 4.81e-05 | 919 | 69 | 12 | GO:0060322 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | FZD1 KMT2D MRTFB LATS1 USP9X ENAH SMARCA4 CHD7 RUNX2 ARID1A EP300 EPN2 | 5.35e-05 | 929 | 69 | 12 | GO:0009792 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | FZD1 NCOA2 MAGEL2 USP9X SMARCA2 HIPK2 SMARCA4 RUNX2 ARID1A TRIM24 CLOCK CREBBP EP300 RCOR2 NCOA5 | 5.36e-05 | 1413 | 69 | 15 | GO:1902679 |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-lysine acetylation | 6.59e-05 | 4 | 69 | 2 | GO:0018076 | |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | 7.30e-05 | 416 | 69 | 8 | GO:0030522 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide-excision repair | 1.23e-04 | 29 | 69 | 3 | GO:2000819 | |
| GeneOntologyBiologicalProcess | aortic smooth muscle cell differentiation | 1.64e-04 | 6 | 69 | 2 | GO:0035887 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | AURKA KMT2D SMARCA2 HIPK2 SMARCA4 CHD7 ARID1A CLOCK CREBBP EP300 | 1.69e-04 | 741 | 69 | 10 | GO:0006338 |
| GeneOntologyBiologicalProcess | behavior | NCOA2 YTHDF1 CELF6 CACNA1A MYO6 HIPK2 GRIA1 CHD7 CREBBP SDK1 EP300 | 1.69e-04 | 891 | 69 | 11 | GO:0007610 |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 1.73e-04 | 83 | 69 | 4 | GO:0006278 | |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | 1.79e-04 | 605 | 69 | 9 | GO:0071407 | |
| GeneOntologyBiologicalProcess | regulation of proteolysis involved in protein catabolic process | 2.10e-04 | 255 | 69 | 6 | GO:1903050 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular response to transforming growth factor beta stimulus | 2.17e-04 | 35 | 69 | 3 | GO:1903846 | |
| GeneOntologyBiologicalProcess | positive regulation of transforming growth factor beta receptor signaling pathway | 2.17e-04 | 35 | 69 | 3 | GO:0030511 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA-binding transcription factor activity | 2.38e-04 | 261 | 69 | 6 | GO:0051091 | |
| GeneOntologyBiologicalProcess | positive regulation of binding | 2.63e-04 | 170 | 69 | 5 | GO:0051099 | |
| GeneOntologyBiologicalProcess | response to steroid hormone | 2.80e-04 | 381 | 69 | 7 | GO:0048545 | |
| GeneOntologyBiologicalProcess | regulation of mitotic metaphase/anaphase transition | 2.90e-04 | 95 | 69 | 4 | GO:0030071 | |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair | 2.90e-04 | 95 | 69 | 4 | GO:2000781 | |
| GeneOntologyBiologicalProcess | neuron projection development | FZD1 YTHDF1 CACNA1A AURKA MRTFB MYO6 USP9X ENAH ROBO2 CREBBP CAPRIN1 SDK1 EP300 | 2.94e-04 | 1285 | 69 | 13 | GO:0031175 |
| GeneOntologyBiologicalProcess | neuron development | FZD1 YTHDF1 CACNA1A AURKA MRTFB MYO6 USP9X ENAH SYN1 ROBO2 CREBBP CAPRIN1 SDK1 EP300 | 2.94e-04 | 1463 | 69 | 14 | GO:0048666 |
| GeneOntologyBiologicalProcess | DNA repair | ERVK-6 USP9X ERVK-8 SMARCA2 SMARCA4 ERVK-7 ERVK-10 ARID1A CREBBP | 2.97e-04 | 648 | 69 | 9 | GO:0006281 |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | 3.25e-04 | 178 | 69 | 5 | GO:0006261 | |
| GeneOntologyBiologicalProcess | regulation of metaphase/anaphase transition of cell cycle | 3.27e-04 | 98 | 69 | 4 | GO:1902099 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of mitotic cell cycle | 3.53e-04 | 100 | 69 | 4 | GO:0007091 | |
| GeneOntologyBiologicalProcess | regulation of G0 to G1 transition | 3.75e-04 | 42 | 69 | 3 | GO:0070316 | |
| GeneOntologyBiologicalProcess | PML body organization | 3.91e-04 | 9 | 69 | 2 | GO:0030578 | |
| GeneOntologyBiologicalProcess | response to estrogen | 3.95e-04 | 103 | 69 | 4 | GO:0043627 | |
| GeneOntologyBiologicalProcess | regulation of miRNA metabolic process | 3.95e-04 | 103 | 69 | 4 | GO:2000628 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of cell cycle | 3.95e-04 | 103 | 69 | 4 | GO:0044784 | |
| GeneOntologyBiologicalProcess | G0 to G1 transition | 4.30e-04 | 44 | 69 | 3 | GO:0045023 | |
| GeneOntologyBiologicalProcess | synapse organization | 4.46e-04 | 685 | 69 | 9 | GO:0050808 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 4.48e-04 | 412 | 69 | 7 | GO:0090287 | |
| GeneOntologyBiologicalProcess | signal transduction by p53 class mediator | 4.49e-04 | 191 | 69 | 5 | GO:0072331 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | 5.03e-04 | 850 | 69 | 10 | GO:0071363 | |
| GeneOntologyBiologicalProcess | regulation of sister chromatid segregation | 5.25e-04 | 111 | 69 | 4 | GO:0033045 | |
| GeneOntologyBiologicalProcess | brain development | FZD1 CACNA1A MRTFB PYGO2 USP9X SMARCA4 GRIA1 ROBO2 CHD7 ARID1A | 5.46e-04 | 859 | 69 | 10 | GO:0007420 |
| GeneOntologyBiologicalProcess | embryonic organ development | 5.54e-04 | 561 | 69 | 8 | GO:0048568 | |
| GeneOntologyBiologicalProcess | adult behavior | 5.93e-04 | 203 | 69 | 5 | GO:0030534 | |
| GeneOntologyBiologicalProcess | cell junction assembly | 6.08e-04 | 569 | 69 | 8 | GO:0034329 | |
| GeneOntologyBiologicalProcess | adult walking behavior | 6.27e-04 | 50 | 69 | 3 | GO:0007628 | |
| GeneOntologyBiologicalProcess | response to hormone | NCOA2 KMT2D LATS1 BCAS3 SMARCA4 GRIA1 ARID1A TRIM24 CLOCK EP300 NCOA5 | 6.41e-04 | 1042 | 69 | 11 | GO:0009725 |
| GeneOntologyBiologicalProcess | positive regulation of stem cell population maintenance | 6.65e-04 | 51 | 69 | 3 | GO:1902459 | |
| GeneOntologyBiologicalProcess | androgen receptor signaling pathway | 6.65e-04 | 51 | 69 | 3 | GO:0030521 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | NCOA2 KMT2D LATS1 SMARCA4 GRIA1 ARID1A TRIM24 CLOCK CREBBP SDK1 EP300 | 6.72e-04 | 1048 | 69 | 11 | GO:0014070 |
| GeneOntologyBiologicalProcess | response to growth factor | 6.76e-04 | 883 | 69 | 10 | GO:0070848 | |
| GeneOntologyBiologicalProcess | regulation of signal transduction by p53 class mediator | 6.82e-04 | 119 | 69 | 4 | GO:1901796 | |
| GeneOntologyBiologicalProcess | miRNA metabolic process | 6.82e-04 | 119 | 69 | 4 | GO:0010586 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 6.89e-04 | 443 | 69 | 7 | GO:1903311 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 7.07e-04 | 445 | 69 | 7 | GO:0141091 | |
| GeneOntologyBiologicalProcess | regulation of glucocorticoid receptor signaling pathway | 7.12e-04 | 12 | 69 | 2 | GO:2000322 | |
| GeneOntologyBiologicalProcess | cardiac chamber development | 7.21e-04 | 212 | 69 | 5 | GO:0003205 | |
| GeneOntologyBiologicalProcess | chromatin organization | AURKA KMT2D SMARCA2 HIPK2 SMARCA4 CHD7 ARID1A CLOCK CREBBP EP300 | 7.56e-04 | 896 | 69 | 10 | GO:0006325 |
| GeneOntologyBiologicalProcess | positive regulation of myoblast differentiation | 7.87e-04 | 54 | 69 | 3 | GO:0045663 | |
| GeneOntologyBiologicalProcess | RNA localization | 8.01e-04 | 217 | 69 | 5 | GO:0006403 | |
| GeneOntologyBiologicalProcess | vascular associated smooth muscle cell differentiation | 8.30e-04 | 55 | 69 | 3 | GO:0035886 | |
| GeneOntologyBiologicalProcess | regulation of catabolic process | YTHDF1 AURKA LATS1 UBQLN2 ERN1 RBM33 USP9X HIPK2 CAPRIN1 EP300 YTHDF2 KHSRP | 8.36e-04 | 1252 | 69 | 12 | GO:0009894 |
| GeneOntologyBiologicalProcess | mRNA metabolic process | NCOA2 YTHDF1 CELF6 TIA1 ERN1 RBM33 HNRNPUL1 CAPRIN1 YTHDF2 KHSRP | 9.03e-04 | 917 | 69 | 10 | GO:0016071 |
| GeneOntologyBiologicalProcess | chromosome segregation | 9.15e-04 | 465 | 69 | 7 | GO:0007059 | |
| GeneOntologyBiologicalProcess | estrogen receptor signaling pathway | 9.21e-04 | 57 | 69 | 3 | GO:0030520 | |
| GeneOntologyBiologicalProcess | epithelium development | FZD1 FOXJ2 LATS1 PYGO2 MYO6 ENAH SMARCA4 ROBO2 CHD7 ARID1A CLOCK CYSRT1 EP300 | 1.04e-03 | 1469 | 69 | 13 | GO:0060429 |
| GeneOntologyBiologicalProcess | cardiac septum development | 1.06e-03 | 134 | 69 | 4 | GO:0003279 | |
| GeneOntologyBiologicalProcess | walking behavior | 1.07e-03 | 60 | 69 | 3 | GO:0090659 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 1.13e-03 | 482 | 69 | 7 | GO:0007178 | |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | 1.13e-03 | 351 | 69 | 6 | GO:0048562 | |
| GeneOntologyBiologicalProcess | cell cycle phase transition | 1.14e-03 | 627 | 69 | 8 | GO:0044770 | |
| GeneOntologyBiologicalProcess | regulation of chromosome segregation | 1.22e-03 | 139 | 69 | 4 | GO:0051983 | |
| GeneOntologyBiologicalProcess | nuclear chromosome segregation | 1.22e-03 | 356 | 69 | 6 | GO:0098813 | |
| GeneOntologyBiologicalProcess | forebrain development | 1.22e-03 | 489 | 69 | 7 | GO:0030900 | |
| GeneOntologyBiologicalProcess | face development | 1.23e-03 | 63 | 69 | 3 | GO:0060324 | |
| GeneOntologyBiologicalProcess | N-terminal protein amino acid acetylation | 1.28e-03 | 16 | 69 | 2 | GO:0006474 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to heat | 1.28e-03 | 16 | 69 | 2 | GO:1900034 | |
| GeneOntologyBiologicalProcess | rhythmic process | 1.29e-03 | 360 | 69 | 6 | GO:0048511 | |
| GeneOntologyBiologicalProcess | protein localization to nucleus | 1.33e-03 | 362 | 69 | 6 | GO:0034504 | |
| GeneOntologyBiologicalProcess | transcription initiation-coupled chromatin remodeling | 1.35e-03 | 65 | 69 | 3 | GO:0045815 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA repair | 1.35e-03 | 143 | 69 | 4 | GO:0045739 | |
| GeneOntologyCellularComponent | cytoplasmic stress granule | 7.60e-07 | 96 | 69 | 6 | GO:0010494 | |
| GeneOntologyCellularComponent | perichromatin fibrils | 1.90e-06 | 8 | 69 | 3 | GO:0005726 | |
| GeneOntologyCellularComponent | bBAF complex | 4.06e-06 | 10 | 69 | 3 | GO:0140092 | |
| GeneOntologyCellularComponent | npBAF complex | 1.22e-05 | 14 | 69 | 3 | GO:0071564 | |
| GeneOntologyCellularComponent | nBAF complex | 1.87e-05 | 16 | 69 | 3 | GO:0071565 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 2.95e-05 | 269 | 69 | 7 | GO:0036464 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 4.46e-05 | 287 | 69 | 7 | GO:0035770 | |
| GeneOntologyCellularComponent | chromatin | FOXJ2 NCOA2 EBF3 BCAS3 SMARCA2 SMARCA4 POU2F2 CHD7 RUNX2 ARID1A TRIM24 CLOCK CREBBP EP300 RCOR2 | 7.80e-05 | 1480 | 69 | 15 | GO:0000785 |
| GeneOntologyCellularComponent | SWI/SNF complex | 1.31e-04 | 30 | 69 | 3 | GO:0016514 | |
| GeneOntologyCellularComponent | transcription regulator complex | 7.55e-04 | 596 | 69 | 8 | GO:0005667 | |
| GeneOntologyCellularComponent | GBAF complex | 9.52e-04 | 14 | 69 | 2 | GO:0140288 | |
| GeneOntologyCellularComponent | brahma complex | 9.52e-04 | 14 | 69 | 2 | GO:0035060 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | NCOA2 KMT2D PYGO2 BUB1B MED12L SMARCA2 HIPK2 SMARCA4 ARID1A CLOCK CREBBP RCOR2 | 1.69e-03 | 1377 | 69 | 12 | GO:0140513 |
| GeneOntologyCellularComponent | euchromatin | 1.74e-03 | 72 | 69 | 3 | GO:0000791 | |
| GeneOntologyCellularComponent | postsynapse | NCOA2 CACNA1A AURKA SYN3 MYO6 USP9X SYN1 GRIA1 ROBO2 CAPRIN1 | 1.79e-03 | 1018 | 69 | 10 | GO:0098794 |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 2.05e-03 | 272 | 69 | 5 | GO:0090575 | |
| GeneOntologyCellularComponent | outer kinetochore | 2.83e-03 | 24 | 69 | 2 | GO:0000940 | |
| GeneOntologyCellularComponent | kinetochore | 3.03e-03 | 181 | 69 | 4 | GO:0000776 | |
| GeneOntologyCellularComponent | extrinsic component of synaptic vesicle membrane | 3.07e-03 | 25 | 69 | 2 | GO:0098850 | |
| GeneOntologyCellularComponent | condensed chromosome | 3.45e-03 | 307 | 69 | 5 | GO:0000793 | |
| GeneOntologyCellularComponent | postsynaptic density | 3.72e-03 | 451 | 69 | 6 | GO:0014069 | |
| GeneOntologyCellularComponent | condensed chromosome, centromeric region | 3.81e-03 | 193 | 69 | 4 | GO:0000779 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 3.95e-03 | 96 | 69 | 3 | GO:0070603 | |
| GeneOntologyCellularComponent | P-body | 4.68e-03 | 102 | 69 | 3 | GO:0000932 | |
| GeneOntologyCellularComponent | asymmetric synapse | 4.88e-03 | 477 | 69 | 6 | GO:0032279 | |
| HumanPheno | Aggressive behavior | CACNA1A MAGEL2 EBF3 USP9X MED12L SMARCA2 SMARCA4 SYN1 GRIA1 CHD7 ARID1A CREBBP CAPRIN1 EP300 | 1.57e-08 | 516 | 25 | 14 | HP:0000718 |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | CACNA1A MAGEL2 EBF3 USP9X MED12L SMARCA2 SMARCA4 SYN1 GRIA1 CHD7 ARID1A CREBBP CAPRIN1 EP300 | 1.57e-08 | 516 | 25 | 14 | HP:0006919 |
| HumanPheno | Prominent fingertip pads | 6.03e-08 | 46 | 25 | 6 | HP:0001212 | |
| HumanPheno | Prominent digit pad | 7.85e-08 | 48 | 25 | 6 | HP:0011298 | |
| HumanPheno | Thin upper lip vermilion | KMT2D MAGEL2 EBF3 USP9X MED12L SMARCA2 SMARCA4 ARID1A CREBBP CAPRIN1 EP300 | 1.85e-07 | 339 | 25 | 11 | HP:0000219 |
| HumanPheno | Thin lips | KMT2D MAGEL2 EBF3 USP9X MED12L SMARCA2 SMARCA4 ARID1A CREBBP CAPRIN1 EP300 | 1.85e-07 | 339 | 25 | 11 | HP:0000213 |
| HumanPheno | Thin vermilion border | KMT2D MAGEL2 EBF3 USP9X MED12L SMARCA2 SMARCA4 RUNX2 ARID1A CREBBP CAPRIN1 EP300 | 2.29e-07 | 433 | 25 | 12 | HP:0000233 |
| HumanPheno | Unsteady gait | CACNA1A EBF3 USP9X BUB1B CIZ1 SMARCA4 CHD7 ARID1A CREBBP CAPRIN1 EP300 | 3.14e-07 | 357 | 25 | 11 | HP:0002317 |
| HumanPheno | Thick eyebrow | 4.07e-07 | 154 | 25 | 8 | HP:0000574 | |
| HumanPheno | Abnormality of upper lip vermillion | CACNA1A KMT2D MAGEL2 EBF3 USP9X MED12L SMARCA2 SMARCA4 ARID1A CREBBP CAPRIN1 EP300 | 4.90e-07 | 464 | 25 | 12 | HP:0011339 |
| HumanPheno | Autistic behavior | CACNA1A KMT2D MAGEL2 USP9X MED12L SMARCA2 SMARCA4 SYN1 GRIA1 CHD7 ARID1A CREBBP CAPRIN1 EP300 | 5.21e-07 | 678 | 25 | 14 | HP:0000729 |
| HumanPheno | Abnormal upper lip morphology | CACNA1A KMT2D MAGEL2 EBF3 BCAS3 USP9X BUB1B MED12L SMARCA2 SMARCA4 CHD7 RUNX2 ARID1A CREBBP CAPRIN1 EP300 | 1.11e-06 | 980 | 25 | 16 | HP:0000177 |
| HumanPheno | Dimple chin | 1.32e-06 | 18 | 25 | 4 | HP:0010751 | |
| HumanPheno | Impairment in personality functioning | CACNA1A MAGEL2 UBQLN2 TIA1 EBF3 USP9X CIZ1 MED12L SMARCA2 SMARCA4 SYN1 GRIA1 CHD7 ARID1A CREBBP CAPRIN1 EP300 | 1.36e-06 | 1141 | 25 | 17 | HP:0031466 |
| HumanPheno | Diagnostic behavioral phenotype | CACNA1A KMT2D MAGEL2 USP9X MED12L SMARCA2 SMARCA4 SYN1 GRIA1 CHD7 ARID1A CREBBP CAPRIN1 EP300 | 1.75e-06 | 747 | 25 | 14 | HP:0025783 |
| HumanPheno | Large foramen magnum | 2.07e-06 | 6 | 25 | 3 | HP:0002700 | |
| HumanPheno | Hyperactivity | CACNA1A MAGEL2 EBF3 MED12L SMARCA2 SMARCA4 GRIA1 CHD7 ARID1A CREBBP CAPRIN1 EP300 | 3.61e-06 | 558 | 25 | 12 | HP:0000752 |
| HumanPheno | Disinhibition | CACNA1A MAGEL2 EBF3 USP9X MED12L SMARCA2 SMARCA4 SYN1 GRIA1 CHD7 ARID1A CREBBP CAPRIN1 EP300 | 4.52e-06 | 807 | 25 | 14 | HP:0000734 |
| HumanPheno | Inappropriate behavior | CACNA1A MAGEL2 EBF3 USP9X MED12L SMARCA2 SMARCA4 SYN1 GRIA1 CHD7 ARID1A CREBBP CAPRIN1 EP300 | 4.52e-06 | 807 | 25 | 14 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | CACNA1A MAGEL2 EBF3 USP9X MED12L SMARCA2 SMARCA4 SYN1 GRIA1 CHD7 ARID1A CREBBP CAPRIN1 EP300 | 4.52e-06 | 807 | 25 | 14 | HP:5200123 |
| HumanPheno | Social disinhibition | CACNA1A MAGEL2 EBF3 USP9X MED12L SMARCA2 SMARCA4 SYN1 GRIA1 CHD7 ARID1A CREBBP CAPRIN1 EP300 | 4.52e-06 | 807 | 25 | 14 | HP:5200029 |
| HumanPheno | Narrow nasal bridge | 4.56e-06 | 53 | 25 | 5 | HP:0000446 | |
| HumanPheno | Clinodactyly | KMT2D MAGEL2 EBF3 BUB1B SMARCA2 SMARCA4 CHD7 RUNX2 ARID1A CREBBP CAPRIN1 EP300 | 4.87e-06 | 574 | 25 | 12 | HP:0030084 |
| HumanPheno | Abnormal lip morphology | CACNA1A KMT2D MAGEL2 EBF3 BCAS3 USP9X BUB1B MED12L SMARCA2 SMARCA4 GRIA1 CHD7 RUNX2 ARID1A CREBBP CAPRIN1 EP300 | 5.23e-06 | 1249 | 25 | 17 | HP:0000159 |
| HumanPheno | Low hanging columella | 6.02e-06 | 56 | 25 | 5 | HP:0009765 | |
| HumanPheno | Abnormal posterior cranial fossa morphology | 6.31e-06 | 221 | 25 | 8 | HP:0000932 | |
| HumanPheno | Cerebellar malformation | CACNA1A KMT2D EBF3 USP9X BUB1B SMARCA2 SMARCA4 CHD7 ARID1A CREBBP EP300 | 7.01e-06 | 487 | 25 | 11 | HP:0002438 |
| HumanPheno | Wide nasal base | 8.54e-06 | 28 | 25 | 4 | HP:0012810 | |
| HumanPheno | Pilomatrixoma | 8.61e-06 | 9 | 25 | 3 | HP:0030434 | |
| HumanPheno | Abnormality of the philtrum | KMT2D MAGEL2 EBF3 BCAS3 USP9X BUB1B MED12L SMARCA2 SMARCA4 RUNX2 ARID1A CREBBP EP300 | 8.94e-06 | 726 | 25 | 13 | HP:0000288 |
| HumanPheno | Abnormal 5th finger morphology | KMT2D EBF3 BUB1B SMARCA2 SMARCA4 CHD7 RUNX2 ARID1A CREBBP CAPRIN1 EP300 | 1.08e-05 | 509 | 25 | 11 | HP:0004207 |
| HumanPheno | Abnormally increased volition | CACNA1A MAGEL2 EBF3 USP9X MED12L SMARCA2 SMARCA4 SYN1 GRIA1 CHD7 ARID1A CREBBP CAPRIN1 EP300 | 1.11e-05 | 869 | 25 | 14 | HP:5200263 |
| HumanPheno | Abnormal nasal base norphology | 1.14e-05 | 30 | 25 | 4 | HP:0012808 | |
| HumanPheno | Abnormal stomach morphology | CACNA1A AURKA KMT2D MAGEL2 EBF3 USP9X BUB1B MED12L SMARCA2 GRIA1 CHD7 CREBBP EP300 | 1.14e-05 | 742 | 25 | 13 | HP:0002577 |
| HumanPheno | Abnormal skull base morphology | 1.24e-05 | 242 | 25 | 8 | HP:0002693 | |
| HumanPheno | Gastroesophageal reflux | CACNA1A KMT2D MAGEL2 EBF3 USP9X MED12L SMARCA2 GRIA1 CHD7 CREBBP EP300 | 1.25e-05 | 517 | 25 | 11 | HP:0002020 |
| HumanPheno | Congenital abnormal hair pattern | KMT2D MAGEL2 EBF3 SMARCA2 SMARCA4 ARID1A CREBBP CAPRIN1 EP300 | 1.35e-05 | 327 | 25 | 9 | HP:0011361 |
| HumanPheno | Gait disturbance | CACNA1A MAGEL2 UBQLN2 TIA1 EBF3 BCAS3 USP9X BUB1B CIZ1 SMARCA2 SMARCA4 CHD7 ARID1A TFG CREBBP CAPRIN1 EP300 | 1.73e-05 | 1356 | 25 | 17 | HP:0001288 |
| HumanPheno | Abnormal social development | CACNA1A MAGEL2 EBF3 USP9X MED12L SMARCA2 SMARCA4 SYN1 GRIA1 CHD7 ARID1A CREBBP CAPRIN1 EP300 | 1.88e-05 | 908 | 25 | 14 | HP:0025732 |
| HumanPheno | Postnatal growth retardation | 1.98e-05 | 258 | 25 | 8 | HP:0008897 | |
| HumanPheno | Plantar crease between first and second toes | 2.31e-05 | 2 | 25 | 2 | HP:0008107 | |
| HumanPheno | Aortic isthmus hypoplasia | 2.31e-05 | 2 | 25 | 2 | HP:0034227 | |
| HumanPheno | High axial triradius | 2.31e-05 | 2 | 25 | 2 | HP:0001042 | |
| HumanPheno | Radial deviation of finger | KMT2D MAGEL2 EBF3 BUB1B SMARCA2 CHD7 RUNX2 CREBBP CAPRIN1 EP300 | 2.44e-05 | 448 | 25 | 10 | HP:0009466 |
| HumanPheno | Abnormal esophagus physiology | CACNA1A KMT2D MAGEL2 UBQLN2 EBF3 USP9X MED12L SMARCA2 GRIA1 CHD7 TFG CREBBP CAPRIN1 EP300 | 2.60e-05 | 933 | 25 | 14 | HP:0025270 |
| HumanPheno | Abnormal eyebrow morphology | CACNA1A KMT2D MAGEL2 EBF3 BCAS3 MED12L SMARCA2 SMARCA4 CHD7 ARID1A CREBBP EP300 | 2.62e-05 | 674 | 25 | 12 | HP:0000534 |
| HumanPheno | Long eyelashes | 2.80e-05 | 129 | 25 | 6 | HP:0000527 | |
| HumanPheno | Radial deviation of the hand or of fingers of the hand | KMT2D MAGEL2 EBF3 BUB1B SMARCA2 CHD7 RUNX2 CREBBP CAPRIN1 EP300 | 2.85e-05 | 456 | 25 | 10 | HP:0009485 |
| HumanPheno | Thick vermilion border | 3.50e-05 | 279 | 25 | 8 | HP:0012471 | |
| HumanPheno | Abnormal fingertip morphology | 3.75e-05 | 203 | 25 | 7 | HP:0001211 | |
| HumanPheno | Abnormal earlobe morphology | 3.94e-05 | 137 | 25 | 6 | HP:0000363 | |
| HumanPheno | Cafe-au-lait spot | 3.94e-05 | 137 | 25 | 6 | HP:0000957 | |
| HumanPheno | Hypospadias | KMT2D USP9X BUB1B MED12L SMARCA2 SMARCA4 ARID1A CREBBP EP300 | 4.26e-05 | 377 | 25 | 9 | HP:0000047 |
| HumanPheno | Abnormal penis morphology | KMT2D MAGEL2 EBF3 USP9X BUB1B MED12L SMARCA2 SMARCA4 CHD7 ARID1A CREBBP EP300 | 4.59e-05 | 712 | 25 | 12 | HP:0000036 |
| HumanPheno | Patent ductus arteriosus | 4.73e-05 | 382 | 25 | 9 | HP:0001643 | |
| HumanPheno | Recurrent maladaptive behavior | CACNA1A MAGEL2 UBQLN2 EBF3 USP9X CIZ1 MED12L SMARCA2 SMARCA4 SYN1 GRIA1 CHD7 ARID1A CREBBP CAPRIN1 EP300 | 5.03e-05 | 1293 | 25 | 16 | HP:5200241 |
| HumanPheno | Abnormality of the hairline | 5.11e-05 | 294 | 25 | 8 | HP:0009553 | |
| HumanPheno | Broad toe | 5.25e-05 | 87 | 25 | 5 | HP:0001837 | |
| HumanPheno | Abnormality of the frontal hairline | 5.43e-05 | 215 | 25 | 7 | HP:0000599 | |
| HumanPheno | Square face | 5.61e-05 | 16 | 25 | 3 | HP:0000321 | |
| HumanPheno | Low anterior hairline | 5.87e-05 | 147 | 25 | 6 | HP:0000294 | |
| HumanPheno | Broad philtrum | 5.87e-05 | 45 | 25 | 4 | HP:0000289 | |
| HumanPheno | Downslanted palpebral fissures | CACNA1A KMT2D EBF3 USP9X BUB1B MED12L SMARCA2 CHD7 CREBBP EP300 | 6.04e-05 | 497 | 25 | 10 | HP:0000494 |
| HumanPheno | Displacement of the urethral meatus | KMT2D USP9X BUB1B MED12L SMARCA2 SMARCA4 ARID1A CREBBP EP300 | 6.42e-05 | 397 | 25 | 9 | HP:0100627 |
| HumanPheno | Abnormal male urethral meatus morphology | KMT2D USP9X BUB1B MED12L SMARCA2 SMARCA4 ARID1A CREBBP EP300 | 6.68e-05 | 399 | 25 | 9 | HP:0032076 |
| HumanPheno | Premature thelarche | 6.79e-05 | 17 | 25 | 3 | HP:0010314 | |
| HumanPheno | Prominent eyelashes | 6.79e-05 | 17 | 25 | 3 | HP:0011231 | |
| HumanPheno | Laryngeal cartilage malformation | 6.92e-05 | 3 | 25 | 2 | HP:0008752 | |
| HumanPheno | Phobia | 6.92e-05 | 3 | 25 | 2 | HP:5200232 | |
| HumanPheno | Agoraphobia | 6.92e-05 | 3 | 25 | 2 | HP:0000756 | |
| HumanPheno | Humoral immunodeficiency | 6.92e-05 | 3 | 25 | 2 | HP:0005363 | |
| HumanPheno | Prominent nasal septum | 6.92e-05 | 3 | 25 | 2 | HP:0005322 | |
| HumanPheno | Radial deviation of thumb terminal phalanx | 6.92e-05 | 3 | 25 | 2 | HP:0005895 | |
| HumanPheno | Feeding difficulties | CACNA1A KMT2D MAGEL2 EBF3 USP9X BUB1B MED12L SMARCA2 SMARCA4 GRIA1 CHD7 ARID1A TFG CREBBP EP300 | 7.17e-05 | 1168 | 25 | 15 | HP:0011968 |
| HumanPheno | Pneumonia | 7.63e-05 | 311 | 25 | 8 | HP:0002090 | |
| HumanPheno | Language impairment | CACNA1A KMT2D MAGEL2 UBQLN2 EBF3 BCAS3 USP9X MED12L SMARCA2 SMARCA4 GRIA1 ARID1A CREBBP CAPRIN1 EP300 | 7.97e-05 | 1178 | 25 | 15 | HP:0002463 |
| HumanPheno | Skin appendage neoplasm | 8.12e-05 | 18 | 25 | 3 | HP:0012842 | |
| HumanPheno | Abnormal nasal bridge morphology | KMT2D MAGEL2 EBF3 BCAS3 USP9X BUB1B MED12L SMARCA2 SMARCA4 CHD7 RUNX2 ARID1A CREBBP EP300 | 8.17e-05 | 1029 | 25 | 14 | HP:0000422 |
| HumanPheno | High, narrow palate | 8.19e-05 | 156 | 25 | 6 | HP:0002705 | |
| HumanPheno | Sandal gap | 8.44e-05 | 96 | 25 | 5 | HP:0001852 | |
| HumanPheno | Reduced impulse control | CACNA1A MAGEL2 EBF3 USP9X MED12L SMARCA2 SMARCA4 SYN1 GRIA1 CHD7 ARID1A CREBBP CAPRIN1 EP300 | 8.45e-05 | 1032 | 25 | 14 | HP:5200045 |
| HumanPheno | Short attention span | CACNA1A MAGEL2 EBF3 MED12L SMARCA2 GRIA1 CHD7 CREBBP CAPRIN1 EP300 | 8.48e-05 | 517 | 25 | 10 | HP:0000736 |
| HumanPheno | Aplasia involving bones of the extremities | KMT2D MAGEL2 EBF3 USP9X SMARCA2 SMARCA4 CHD7 RUNX2 ARID1A TFG CREBBP EP300 | 8.77e-05 | 759 | 25 | 12 | HP:0009825 |
| HumanPheno | Compulsive behaviors | 8.79e-05 | 158 | 25 | 6 | HP:0000722 | |
| HumanPheno | Abnormal columella morphology | 8.87e-05 | 97 | 25 | 5 | HP:0009929 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the extremities | KMT2D MAGEL2 EBF3 USP9X SMARCA2 SMARCA4 CHD7 RUNX2 ARID1A TFG CREBBP EP300 | 9.01e-05 | 761 | 25 | 12 | HP:0045060 |
| HumanPheno | Reduced attention regulation | CACNA1A MAGEL2 EBF3 MED12L SMARCA2 GRIA1 CHD7 CREBBP CAPRIN1 EP300 | 9.84e-05 | 526 | 25 | 10 | HP:5200044 |
| HumanPheno | Clinodactyly of the 5th finger | 9.99e-05 | 420 | 25 | 9 | HP:0004209 | |
| HumanPheno | Clinodactyly of hands | 1.02e-04 | 421 | 25 | 9 | HP:0001157 | |
| HumanPheno | Deviation of the 5th finger | 1.02e-04 | 421 | 25 | 9 | HP:0009179 | |
| HumanPheno | Short finger | 1.04e-04 | 325 | 25 | 8 | HP:0009381 | |
| HumanPheno | Abnormality of dental eruption | 1.09e-04 | 240 | 25 | 7 | HP:0006292 | |
| HumanPheno | Hypertrichosis | 1.10e-04 | 425 | 25 | 9 | HP:0000998 | |
| HumanPheno | Aplasia/Hypoplasia of the earlobes | 1.12e-04 | 53 | 25 | 4 | HP:0009906 | |
| HumanPheno | Abnormal lower lip morphology | 1.15e-04 | 242 | 25 | 7 | HP:0000178 | |
| HumanPheno | Deviation of finger | KMT2D MAGEL2 EBF3 BUB1B SMARCA2 CHD7 RUNX2 CREBBP CAPRIN1 EP300 | 1.17e-04 | 537 | 25 | 10 | HP:0004097 |
| HumanPheno | Aplasia/hypoplasia involving bones of the hand | KMT2D MAGEL2 USP9X SMARCA2 SMARCA4 CHD7 RUNX2 ARID1A CREBBP EP300 | 1.19e-04 | 538 | 25 | 10 | HP:0005927 |
| HumanPheno | Brachydactyly (hand) | 1.20e-04 | 430 | 25 | 9 | HP:0100667 | |
| HumanPheno | Abnormal facial shape | KMT2D MAGEL2 EBF3 BCAS3 USP9X BUB1B MED12L SMARCA2 SMARCA4 CHD7 RUNX2 ARID1A CREBBP CAPRIN1 EP300 | 1.24e-04 | 1221 | 25 | 15 | HP:0001999 |
| HumanPheno | Atrial septal defect | KMT2D MAGEL2 EBF3 USP9X BUB1B SMARCA4 CHD7 ARID1A CREBBP EP300 | 1.25e-04 | 541 | 25 | 10 | HP:0001631 |
| MousePheno | abnormal aggression towards conspecific | 6.59e-06 | 73 | 51 | 5 | MP:0021115 | |
| MousePheno | increased malignant tumor incidence | 2.26e-05 | 237 | 51 | 7 | MP:0002018 | |
| MousePheno | perinatal lethality | CACNA1A MAGEL2 MRTFB LATS1 PYGO2 EBF3 BUB1B ROBO2 POU2F2 RUNX2 ARID1A CREBBP CAPRIN1 EP300 | 3.53e-05 | 1130 | 51 | 14 | MP:0002081 |
| MousePheno | increased locomotor activity | 4.39e-05 | 178 | 51 | 6 | MP:0031391 | |
| MousePheno | decreased circulating luteinizing hormone level | 5.81e-05 | 21 | 51 | 3 | MP:0002773 | |
| MousePheno | nasal bone hypoplasia | 7.79e-05 | 4 | 51 | 2 | MP:0000103 | |
| MousePheno | abnormal forebrain morphology | YTHDF1 KMT2D LATS1 EBF3 ENAH HIPK2 SYN1 ROBO2 CHD7 CERS6 ARID1A CLOCK CREBBP | 8.98e-05 | 1072 | 51 | 13 | MP:0000783 |
| MousePheno | abnormal aggression-related behavior | 9.61e-05 | 127 | 51 | 5 | MP:0002061 | |
| MousePheno | abnormal nervous system development | CACNA1A MRTFB PYGO2 SYN3 USP9X ENAH HIPK2 SMARCA4 SYN1 ROBO2 CHD7 ARID1A CREBBP EP300 | 1.13e-04 | 1257 | 51 | 14 | MP:0003861 |
| MousePheno | short stride length | 1.14e-04 | 69 | 51 | 4 | MP:0001407 | |
| MousePheno | abnormal social/conspecific interaction behavior | 1.29e-04 | 421 | 51 | 8 | MP:0002557 | |
| MousePheno | abnormal vertical activity | 1.73e-04 | 439 | 51 | 8 | MP:0020167 | |
| MousePheno | delayed estrous cycle | 1.94e-04 | 6 | 51 | 2 | MP:0009008 | |
| MousePheno | decreased luteinizing hormone level | 2.11e-04 | 32 | 51 | 3 | MP:0005132 | |
| MousePheno | hyperactivity | NCOA2 KMT2D SYN3 MYO6 CIZ1 SMARCA2 GRIA1 CHD7 CERS6 CLOCK CREBBP SDK1 AGAP3 | 2.20e-04 | 1172 | 51 | 13 | MP:0001399 |
| MousePheno | abnormal stride length | 2.23e-04 | 82 | 51 | 4 | MP:0012690 | |
| MousePheno | abnormal neural tube morphology | 2.52e-04 | 591 | 51 | 9 | MP:0002151 | |
| MousePheno | increased granulocyte number | 2.71e-04 | 597 | 51 | 9 | MP:0000322 | |
| MousePheno | decreased aggression towards mice | 3.00e-04 | 36 | 51 | 3 | MP:0003863 | |
| MousePheno | abnormal mitotic spindle morphology | 3.00e-04 | 36 | 51 | 3 | MP:0009760 | |
| MousePheno | perimembraneous ventricular septal defect | 3.47e-04 | 92 | 51 | 4 | MP:0010418 | |
| MousePheno | ventricular septal defect | 3.56e-04 | 261 | 51 | 6 | MP:0010402 | |
| MousePheno | large anterior fontanelle | 3.60e-04 | 8 | 51 | 2 | MP:0000085 | |
| MousePheno | abnormal anterior fontanelle morphology | 3.60e-04 | 8 | 51 | 2 | MP:0030363 | |
| MousePheno | abnormal interventricular septum membranous part morphology | 3.61e-04 | 93 | 51 | 4 | MP:0008823 | |
| MousePheno | increased classified tumor incidence | 4.35e-04 | 381 | 51 | 7 | MP:0010273 | |
| MousePheno | abnormal classified tumor incidence | 4.56e-04 | 384 | 51 | 7 | MP:0020188 | |
| MousePheno | abnormal heart septum morphology | 4.85e-04 | 388 | 51 | 7 | MP:0006113 | |
| MousePheno | abnormal tumor susceptibility | 5.06e-04 | 650 | 51 | 9 | MP:0002166 | |
| MousePheno | increased sarcoma incidence | 5.13e-04 | 102 | 51 | 4 | MP:0002032 | |
| MousePheno | increased organ/body region tumor incidence | 5.40e-04 | 395 | 51 | 7 | MP:0010274 | |
| MousePheno | abnormal granulocyte number | 5.61e-04 | 805 | 51 | 10 | MP:0020201 | |
| MousePheno | abnormal organ/body region tumor incidence | 5.91e-04 | 401 | 51 | 7 | MP:0013152 | |
| MousePheno | increased tumor incidence | 6.12e-04 | 530 | 51 | 8 | MP:0002020 | |
| MousePheno | postnatal lethality, incomplete penetrance | 6.24e-04 | 669 | 51 | 9 | MP:0011086 | |
| MousePheno | pale yolk sac | 6.82e-04 | 110 | 51 | 4 | MP:0001722 | |
| MousePheno | impaired social transmission of food preference | 7.03e-04 | 11 | 51 | 2 | MP:0002969 | |
| MousePheno | abnormal crista ampullaris neuroepithelium morphology | 7.03e-04 | 11 | 51 | 2 | MP:0004409 | |
| MousePheno | increased hepatobiliary system tumor incidence | 7.06e-04 | 111 | 51 | 4 | MP:0010297 | |
| MousePheno | increased liver tumor incidence | 7.06e-04 | 111 | 51 | 4 | MP:0008019 | |
| MousePheno | abnormal vascular development | 7.09e-04 | 542 | 51 | 8 | MP:0000259 | |
| MousePheno | increased carcinoma incidence | 7.33e-04 | 197 | 51 | 5 | MP:0002038 | |
| MousePheno | abnormal granulocyte morphology | 7.47e-04 | 835 | 51 | 10 | MP:0002441 | |
| MousePheno | abnormal miniature excitatory postsynaptic currents | 8.33e-04 | 116 | 51 | 4 | MP:0004753 | |
| MousePheno | abnormal hepatocyte physiology | 8.33e-04 | 116 | 51 | 4 | MP:0010080 | |
| MousePheno | decreased vertical activity | 8.40e-04 | 203 | 51 | 5 | MP:0002757 | |
| MousePheno | flattened snout | 8.41e-04 | 12 | 51 | 2 | MP:0000447 | |
| MousePheno | abnormal bone marrow cell morphology/development | 9.16e-04 | 706 | 51 | 9 | MP:0002398 | |
| MousePheno | decreased aggression | 9.42e-04 | 53 | 51 | 3 | MP:0005656 | |
| MousePheno | abnormal estrous cycle | 9.45e-04 | 120 | 51 | 4 | MP:0001927 | |
| MousePheno | perinatal lethality, complete penetrance | 9.73e-04 | 712 | 51 | 9 | MP:0011089 | |
| MousePheno | abnormal common carotid artery morphology | 9.92e-04 | 13 | 51 | 2 | MP:0012729 | |
| MousePheno | increased synaptic depression | 9.92e-04 | 13 | 51 | 2 | MP:0002916 | |
| MousePheno | abnormal proestrus | 9.92e-04 | 13 | 51 | 2 | MP:0009013 | |
| MousePheno | decreased grip strength | 1.04e-03 | 575 | 51 | 8 | MP:0010053 | |
| MousePheno | abnormal ovulation cycle | 1.13e-03 | 126 | 51 | 4 | MP:0009344 | |
| MousePheno | impaired discrimination learning | 1.15e-03 | 14 | 51 | 2 | MP:0012296 | |
| MousePheno | abnormal locomotor circadian rhythm | 1.15e-03 | 14 | 51 | 2 | MP:0020477 | |
| MousePheno | abnormal placing response | 1.15e-03 | 14 | 51 | 2 | MP:0001526 | |
| MousePheno | decreased thymocyte number | 1.17e-03 | 127 | 51 | 4 | MP:0000715 | |
| MousePheno | decreased circulating gonadotropin level | 1.35e-03 | 60 | 51 | 3 | MP:0003363 | |
| MousePheno | cyanosis | 1.36e-03 | 226 | 51 | 5 | MP:0001575 | |
| MousePheno | neoplasm | 1.36e-03 | 747 | 51 | 9 | MP:0002006 | |
| MousePheno | abnormal hormone level | NCOA2 CELF6 CACNA1A MAGEL2 LATS1 GRIA1 CHD7 CERS6 RUNX2 CLOCK CREBBP | 1.42e-03 | 1073 | 51 | 11 | MP:0003953 |
| MousePheno | abnormal interventricular septum morphology | 1.46e-03 | 342 | 51 | 6 | MP:0000281 | |
| MousePheno | decreased aggression towards male mice | 1.52e-03 | 16 | 51 | 2 | MP:0003862 | |
| MousePheno | large fontanelles | 1.52e-03 | 16 | 51 | 2 | MP:0030388 | |
| MousePheno | postnatal lethality | CACNA1A MAGEL2 LATS1 TIA1 SMARCA4 ROBO2 CHD7 RUNX2 CREBBP EP300 AGAP3 | 1.54e-03 | 1084 | 51 | 11 | MP:0002082 |
| MousePheno | abnormal inner ear canal morphology | 1.56e-03 | 63 | 51 | 3 | MP:0002729 | |
| MousePheno | abnormal luteinizing hormone level | 1.63e-03 | 64 | 51 | 3 | MP:0003969 | |
| MousePheno | abnormal dendrite morphology | 1.67e-03 | 237 | 51 | 5 | MP:0008143 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | CACNA1A MRTFB PYGO2 EBF3 BUB1B ROBO2 POU2F2 RUNX2 ARID1A CREBBP CAPRIN1 EP300 | 1.67e-03 | 1269 | 51 | 12 | MP:0011111 |
| MousePheno | reduced male fertility | 1.69e-03 | 352 | 51 | 6 | MP:0001922 | |
| MousePheno | increased hepatocyte proliferation | 1.71e-03 | 17 | 51 | 2 | MP:0003893 | |
| MousePheno | abnormal fourth pharyngeal arch artery morphology | 1.71e-03 | 17 | 51 | 2 | MP:0006354 | |
| MousePheno | increased excitatory postsynaptic current amplitude | 1.92e-03 | 18 | 51 | 2 | MP:0011269 | |
| MousePheno | abnormal sixth pharyngeal arch artery morphology | 1.92e-03 | 18 | 51 | 2 | MP:0006355 | |
| MousePheno | abnormal sixth pharyngeal arch morphology | 1.92e-03 | 18 | 51 | 2 | MP:0006347 | |
| MousePheno | abnormal myeloid leukocyte morphology | FZD1 NCOA2 LATS1 ZNF474 CIZ1 CHD7 CERS6 RUNX2 CLOCK CREBBP EP300 NCOA5 | 1.95e-03 | 1292 | 51 | 12 | MP:0008250 |
| MousePheno | impaired learning | 1.95e-03 | 146 | 51 | 4 | MP:0012315 | |
| MousePheno | abnormal tumor incidence | 1.96e-03 | 635 | 51 | 8 | MP:0002019 | |
| MousePheno | decreased hormone level | 1.96e-03 | 635 | 51 | 8 | MP:0014455 | |
| Domain | Bromodomain_CS | 1.96e-08 | 26 | 61 | 5 | IPR018359 | |
| Domain | BROMODOMAIN_1 | 1.26e-07 | 37 | 61 | 5 | PS00633 | |
| Domain | Bromodomain | 1.45e-07 | 38 | 61 | 5 | PF00439 | |
| Domain | BROMODOMAIN_2 | 2.15e-07 | 41 | 61 | 5 | PS50014 | |
| Domain | BROMO | 2.44e-07 | 42 | 61 | 5 | SM00297 | |
| Domain | Bromodomain | 2.44e-07 | 42 | 61 | 5 | IPR001487 | |
| Domain | - | 2.44e-07 | 42 | 61 | 5 | 1.20.920.10 | |
| Domain | BRK | 6.58e-07 | 6 | 61 | 3 | SM00592 | |
| Domain | Nuc_rcpt_coact | 6.58e-07 | 6 | 61 | 3 | IPR009110 | |
| Domain | BRK_domain | 6.58e-07 | 6 | 61 | 3 | IPR006576 | |
| Domain | BRK | 6.58e-07 | 6 | 61 | 3 | PF07533 | |
| Domain | SnAC | 1.05e-05 | 2 | 61 | 2 | SM01314 | |
| Domain | Nuc_rcpt_coact_CREBbp | 1.05e-05 | 2 | 61 | 2 | IPR014744 | |
| Domain | HAT_KAT11 | 1.05e-05 | 2 | 61 | 2 | PF08214 | |
| Domain | KIX | 1.05e-05 | 2 | 61 | 2 | PS50952 | |
| Domain | Gln-Leu-Gln_QLQ | 1.05e-05 | 2 | 61 | 2 | IPR014978 | |
| Domain | ZnF_TAZ | 1.05e-05 | 2 | 61 | 2 | SM00551 | |
| Domain | CBP_P300_HAT | 1.05e-05 | 2 | 61 | 2 | IPR031162 | |
| Domain | DUF902 | 1.05e-05 | 2 | 61 | 2 | PF06001 | |
| Domain | SnAC | 1.05e-05 | 2 | 61 | 2 | IPR029295 | |
| Domain | - | 1.05e-05 | 2 | 61 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 1.05e-05 | 2 | 61 | 2 | IPR010303 | |
| Domain | - | 1.05e-05 | 2 | 61 | 2 | 1.10.1630.10 | |
| Domain | Creb_binding | 1.05e-05 | 2 | 61 | 2 | PF09030 | |
| Domain | SnAC | 1.05e-05 | 2 | 61 | 2 | PF14619 | |
| Domain | QLQ | 1.05e-05 | 2 | 61 | 2 | SM00951 | |
| Domain | - | 1.05e-05 | 2 | 61 | 2 | 1.10.246.20 | |
| Domain | zf-TAZ | 1.05e-05 | 2 | 61 | 2 | PF02135 | |
| Domain | ZF_TAZ | 1.05e-05 | 2 | 61 | 2 | PS50134 | |
| Domain | QLQ | 1.05e-05 | 2 | 61 | 2 | PS51666 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 1.05e-05 | 2 | 61 | 2 | IPR013178 | |
| Domain | QLQ | 1.05e-05 | 2 | 61 | 2 | PF08880 | |
| Domain | KAT11 | 1.05e-05 | 2 | 61 | 2 | SM01250 | |
| Domain | Znf_TAZ | 1.05e-05 | 2 | 61 | 2 | IPR000197 | |
| Domain | KIX_dom | 1.05e-05 | 2 | 61 | 2 | IPR003101 | |
| Domain | KIX | 1.05e-05 | 2 | 61 | 2 | PF02172 | |
| Domain | CBP_P300_HAT | 1.05e-05 | 2 | 61 | 2 | PS51727 | |
| Domain | SYNAPSIN_1 | 3.14e-05 | 3 | 61 | 2 | PS00415 | |
| Domain | SYNAPSIN_2 | 3.14e-05 | 3 | 61 | 2 | PS00416 | |
| Domain | Synapsin_C | 3.14e-05 | 3 | 61 | 2 | PF02750 | |
| Domain | Synapsin_N | 3.14e-05 | 3 | 61 | 2 | PF10581 | |
| Domain | Synapsin_pre-ATP-grasp_dom | 3.14e-05 | 3 | 61 | 2 | IPR020897 | |
| Domain | Synapsin_ATP-bd_dom | 3.14e-05 | 3 | 61 | 2 | IPR020898 | |
| Domain | Synapsin_CS | 3.14e-05 | 3 | 61 | 2 | IPR019735 | |
| Domain | Synapsin_P_site | 3.14e-05 | 3 | 61 | 2 | IPR019736 | |
| Domain | Synapsin | 3.14e-05 | 3 | 61 | 2 | PF02078 | |
| Domain | Synapsin | 3.14e-05 | 3 | 61 | 2 | IPR001359 | |
| Domain | HSA | 6.27e-05 | 4 | 61 | 2 | SM00573 | |
| Domain | SUZ | 6.27e-05 | 4 | 61 | 2 | IPR024771 | |
| Domain | SUZ | 6.27e-05 | 4 | 61 | 2 | PS51673 | |
| Domain | HSA | 6.27e-05 | 4 | 61 | 2 | PS51204 | |
| Domain | HSA_dom | 6.27e-05 | 4 | 61 | 2 | IPR014012 | |
| Domain | HSA | 6.27e-05 | 4 | 61 | 2 | PF07529 | |
| Domain | YTH_domain | 1.04e-04 | 5 | 61 | 2 | IPR007275 | |
| Domain | YTH | 1.04e-04 | 5 | 61 | 2 | PS50882 | |
| Domain | YTH | 1.04e-04 | 5 | 61 | 2 | PF04146 | |
| Domain | PHD | 1.05e-04 | 75 | 61 | 4 | PF00628 | |
| Domain | Znf_PHD-finger | 1.29e-04 | 79 | 61 | 4 | IPR019787 | |
| Domain | SNF2_N | 1.54e-04 | 32 | 61 | 3 | IPR000330 | |
| Domain | SNF2_N | 1.54e-04 | 32 | 61 | 3 | PF00176 | |
| Domain | PHD | 2.04e-04 | 89 | 61 | 4 | SM00249 | |
| Domain | Znf_PHD | 2.23e-04 | 91 | 61 | 4 | IPR001965 | |
| Domain | ZF_PHD_2 | 2.63e-04 | 95 | 61 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 2.73e-04 | 96 | 61 | 4 | PS01359 | |
| Domain | R3H | 3.72e-04 | 9 | 61 | 2 | SM00393 | |
| Domain | R3H | 5.66e-04 | 11 | 61 | 2 | PS51061 | |
| Domain | R3H | 5.66e-04 | 11 | 61 | 2 | PF01424 | |
| Domain | - | 5.66e-04 | 11 | 61 | 2 | 3.30.1370.50 | |
| Domain | R3H_dom | 5.66e-04 | 11 | 61 | 2 | IPR001374 | |
| Domain | - | 8.00e-04 | 13 | 61 | 2 | 3.40.50.20 | |
| Domain | PreATP-grasp_dom | 9.31e-04 | 14 | 61 | 2 | IPR016185 | |
| Domain | - | 1.07e-03 | 15 | 61 | 2 | 3.30.1490.20 | |
| Domain | Zinc_finger_PHD-type_CS | 1.25e-03 | 65 | 61 | 3 | IPR019786 | |
| Domain | Znf_FYVE_PHD | 1.36e-03 | 147 | 61 | 4 | IPR011011 | |
| Domain | ZZ | 1.55e-03 | 18 | 61 | 2 | PF00569 | |
| Domain | ATP_grasp_subdomain_1 | 1.55e-03 | 18 | 61 | 2 | IPR013815 | |
| Domain | ZF_ZZ_2 | 1.55e-03 | 18 | 61 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 1.55e-03 | 18 | 61 | 2 | PS01357 | |
| Domain | - | 1.55e-03 | 18 | 61 | 2 | 3.30.470.20 | |
| Domain | Znf_ZZ | 1.73e-03 | 19 | 61 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 1.73e-03 | 19 | 61 | 2 | SM00291 | |
| Domain | - | 2.12e-03 | 21 | 61 | 2 | 1.10.720.30 | |
| Domain | SAP | 2.32e-03 | 22 | 61 | 2 | PF02037 | |
| Domain | SAP | 2.54e-03 | 23 | 61 | 2 | SM00513 | |
| Domain | PAS | 3.00e-03 | 25 | 61 | 2 | PF00989 | |
| Domain | SAP | 3.00e-03 | 25 | 61 | 2 | PS50800 | |
| Domain | PAS_fold | 3.00e-03 | 25 | 61 | 2 | IPR013767 | |
| Domain | SAP_dom | 3.00e-03 | 25 | 61 | 2 | IPR003034 | |
| Domain | PAC | 3.24e-03 | 26 | 61 | 2 | IPR001610 | |
| Domain | PAC | 3.24e-03 | 26 | 61 | 2 | SM00086 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 2.30e-08 | 26 | 48 | 5 | MM14793 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 1.48e-07 | 37 | 48 | 5 | M27797 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 6.04e-07 | 91 | 48 | 6 | M27101 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 8.27e-07 | 22 | 48 | 4 | MM1370 | |
| Pathway | PID_AR_TF_PATHWAY | 9.38e-07 | 53 | 48 | 5 | M151 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 1.20e-06 | 24 | 48 | 4 | M13404 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 1.20e-06 | 237 | 48 | 8 | M27786 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 2.62e-06 | 65 | 48 | 5 | M39682 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 3.35e-06 | 272 | 48 | 8 | M29619 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 5.09e-06 | 34 | 48 | 4 | MM15531 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 7.07e-06 | 301 | 48 | 8 | MM15983 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 1.27e-05 | 233 | 48 | 7 | M27099 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 1.31e-05 | 14 | 48 | 3 | M27808 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 1.45e-05 | 44 | 48 | 4 | M27295 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 1.50e-05 | 158 | 48 | 6 | MM14791 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 1.64e-05 | 15 | 48 | 3 | MM1439 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 2.01e-05 | 16 | 48 | 3 | M27121 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 2.01e-05 | 16 | 48 | 3 | M8516 | |
| Pathway | REACTOME_HEME_SIGNALING | 2.24e-05 | 49 | 48 | 4 | M41832 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 2.92e-05 | 18 | 48 | 3 | M26942 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 4.06e-05 | 20 | 48 | 3 | M27881 | |
| Pathway | WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX | 4.72e-05 | 21 | 48 | 3 | M39593 | |
| Pathway | PID_RB_1PATHWAY | 6.88e-05 | 65 | 48 | 4 | M279 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 8.08e-05 | 25 | 48 | 3 | M27880 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 9.20e-05 | 70 | 48 | 4 | M938 | |
| Pathway | REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION | 1.02e-04 | 27 | 48 | 3 | M26943 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 1.13e-04 | 5 | 48 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 1.13e-04 | 5 | 48 | 2 | M48020 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 1.13e-04 | 5 | 48 | 2 | M48023 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 1.13e-04 | 5 | 48 | 2 | M27228 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 1.17e-04 | 330 | 48 | 7 | M7847 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 1.27e-04 | 29 | 48 | 3 | M48076 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 1.41e-04 | 30 | 48 | 3 | M207 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 1.51e-04 | 239 | 48 | 6 | MM14756 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 1.66e-04 | 153 | 48 | 5 | MM15522 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 1.69e-04 | 6 | 48 | 2 | M22062 | |
| Pathway | PID_SMAD2_3NUCLEAR_PATHWAY | 1.70e-04 | 82 | 48 | 4 | M2 | |
| Pathway | PID_REG_GR_PATHWAY | 1.70e-04 | 82 | 48 | 4 | M115 | |
| Pathway | PID_CMYB_PATHWAY | 1.87e-04 | 84 | 48 | 4 | M195 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 2.25e-04 | 35 | 48 | 3 | M47969 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 2.36e-04 | 7 | 48 | 2 | MM1573 | |
| Pathway | REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_MYELOID_CELLS | 2.36e-04 | 7 | 48 | 2 | M27799 | |
| Pathway | WP_ANDROGEN_RECEPTOR_SIGNALING | 2.54e-04 | 91 | 48 | 4 | M39700 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 3.14e-04 | 8 | 48 | 2 | M22058 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 3.14e-04 | 8 | 48 | 2 | M48022 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 3.14e-04 | 8 | 48 | 2 | M48024 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 3.14e-04 | 8 | 48 | 2 | M46443 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION | 3.87e-04 | 42 | 48 | 3 | M48237 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 3.87e-04 | 42 | 48 | 3 | M17541 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 3.87e-04 | 42 | 48 | 3 | M27272 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY | 4.03e-04 | 9 | 48 | 2 | M47451 | |
| Pathway | REACTOME_SUMOYLATION | 4.41e-04 | 189 | 48 | 5 | M27214 | |
| Pathway | BIOCARTA_HSWI_SNF_PATHWAY | 5.02e-04 | 10 | 48 | 2 | MM1532 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 5.02e-04 | 10 | 48 | 2 | MM15535 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 5.02e-04 | 10 | 48 | 2 | M27945 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY | 5.24e-04 | 110 | 48 | 4 | MM15977 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 5.41e-04 | 47 | 48 | 3 | M7946 | |
| Pathway | PID_HES_HEY_PATHWAY | 5.75e-04 | 48 | 48 | 3 | M288 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 5.75e-04 | 48 | 48 | 3 | M611 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 6.12e-04 | 49 | 48 | 3 | M618 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 6.12e-04 | 11 | 48 | 2 | MM1521 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 6.12e-04 | 11 | 48 | 2 | M48021 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 6.12e-04 | 11 | 48 | 2 | M26924 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 6.83e-04 | 118 | 48 | 4 | M27316 | |
| Pathway | WP_SYNAPTIC_VESICLE_PATHWAY | 6.88e-04 | 51 | 48 | 3 | M39457 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 7.27e-04 | 211 | 48 | 5 | MM14502 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 7.33e-04 | 12 | 48 | 2 | M7968 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 7.33e-04 | 12 | 48 | 2 | M27765 | |
| Pathway | REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 7.33e-04 | 12 | 48 | 2 | M27159 | |
| Pathway | BIOCARTA_HSWI_SNF_PATHWAY | 7.33e-04 | 12 | 48 | 2 | M22006 | |
| Pathway | WP_TGFBETA_SIGNALING_PATHWAY | 7.70e-04 | 53 | 48 | 3 | MM15880 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING | 8.58e-04 | 55 | 48 | 3 | M39351 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | 9.95e-04 | 768 | 48 | 9 | MM14851 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 1.00e-03 | 58 | 48 | 3 | M29616 | |
| Pathway | PID_P53_REGULATION_PATHWAY | 1.05e-03 | 59 | 48 | 3 | M261 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 1.05e-03 | 59 | 48 | 3 | M39886 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 1.16e-03 | 15 | 48 | 2 | MM1339 | |
| Pathway | REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION | 1.16e-03 | 15 | 48 | 2 | M603 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 1.16e-03 | 15 | 48 | 2 | M10183 | |
| Pathway | PID_ERB_GENOMIC_PATHWAY | 1.16e-03 | 15 | 48 | 2 | M119 | |
| Pathway | WP_RUBINSTEINTAYBI_SYNDROME_1 | 1.16e-03 | 15 | 48 | 2 | M48323 | |
| Pathway | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | 1.16e-03 | 15 | 48 | 2 | M953 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 1.19e-03 | 137 | 48 | 4 | M48232 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.32e-03 | 16 | 48 | 2 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.32e-03 | 16 | 48 | 2 | MM1420 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES | 1.32e-03 | 16 | 48 | 2 | M27940 | |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | 1.36e-03 | 142 | 48 | 4 | M27233 | |
| Pathway | PID_HIF1_TFPATHWAY | 1.46e-03 | 66 | 48 | 3 | M255 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 1.49e-03 | 17 | 48 | 2 | MM1509 | |
| Pathway | REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA | 1.49e-03 | 17 | 48 | 2 | M48025 | |
| Pathway | REACTOME_FORMATION_OF_PARAXIAL_MESODERM | 1.66e-03 | 69 | 48 | 3 | M46439 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 1.66e-03 | 254 | 48 | 5 | M27131 | |
| Pathway | REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE | 1.68e-03 | 18 | 48 | 2 | MM14702 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G2_CELL_CYCLE_ARREST | 1.68e-03 | 18 | 48 | 2 | M27633 | |
| Pathway | REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE | 1.68e-03 | 18 | 48 | 2 | M27043 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 1.68e-03 | 18 | 48 | 2 | MM14775 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 1.73e-03 | 70 | 48 | 3 | M3115 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 1.87e-03 | 19 | 48 | 2 | M18933 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ANTI_OXIDANT_DETOXIFICATION_ENZYMES | 1.87e-03 | 19 | 48 | 2 | M46442 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | AURKA KMT2D USP9X SMARCA2 HIPK2 SMARCA4 POU2F2 RUNX2 ARID1A CREBBP MAML3 EP300 | 1.91e-03 | 1387 | 48 | 12 | M734 |
| Pubmed | NCOA2 YTHDF1 KMT2D PYGO2 MYO6 RBM33 USP9X SMARCA2 HIPK2 SMARCA4 C15orf39 R3HDM2 CHD7 HNRNPUL1 R3HDM1 ARID1A TRIM24 CREBBP CAPRIN1 EP300 YTHDF2 PYGO1 | 6.77e-14 | 1429 | 72 | 22 | 35140242 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | NCOA2 YTHDF1 KMT2D PYGO2 RBM33 SMARCA2 ARID1A TRIM24 TFG CREBBP MAML3 EP300 YTHDF2 NCOA5 | 5.60e-13 | 457 | 72 | 14 | 32344865 |
| Pubmed | 7.87e-12 | 83 | 72 | 8 | 28794006 | ||
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 1.69e-11 | 4 | 72 | 4 | 10469592 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 2.18e-11 | 94 | 72 | 8 | 21542922 | |
| Pubmed | 2.58e-11 | 12 | 72 | 5 | 14557543 | ||
| Pubmed | 3.08e-11 | 152 | 72 | 9 | 38360978 | ||
| Pubmed | NCOA2 AURKA KMT2D RBM33 EBF3 SMARCA2 SMARCA4 C15orf39 CHD7 HNRNPUL1 RUNX2 ARID1A TRIM24 CREBBP CAPRIN1 EP300 KHSRP | 7.72e-11 | 1103 | 72 | 17 | 34189442 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 8.43e-11 | 5 | 72 | 4 | 12629516 | |
| Pubmed | NCOA2 KMT2D MRTFB LATS1 USP9X ENAH BUB1B CIZ1 SMARCA4 ARID1A CREBBP EP300 KHSRP | 9.95e-11 | 549 | 72 | 13 | 38280479 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | NCOA2 KMT2D PYGO2 SMARCA2 SMARCA4 C15orf39 CHD7 ARID1A TRIM24 CREBBP EP300 | 1.65e-10 | 351 | 72 | 11 | 38297188 |
| Pubmed | 2.00e-10 | 17 | 72 | 5 | 19183483 | ||
| Pubmed | NCOA2 KMT2D PYGO2 RBM33 SMARCA2 SMARCA4 CHD7 ARID1A TRIM24 CREBBP | 2.20e-10 | 268 | 72 | 10 | 33640491 | |
| Pubmed | Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1. | 2.31e-10 | 40 | 72 | 6 | 34585037 | |
| Pubmed | A switch from hBrm to Brg1 at IFNγ-activated sequences mediates the activation of human genes. | 5.88e-10 | 7 | 72 | 4 | 21079652 | |
| Pubmed | Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. | 5.88e-10 | 7 | 72 | 4 | 9590696 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | NCOA2 KMT2D CIZ1 SMARCA2 SMARCA4 C15orf39 CHD7 ARID1A TRIM24 CREBBP EP300 | 6.21e-10 | 398 | 72 | 11 | 35016035 |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | NCOA2 KMT2D SMARCA2 HIPK2 HNRNPUL1 ARID1A TRIM24 EP300 KHSRP | 8.29e-10 | 220 | 72 | 9 | 35785414 |
| Pubmed | 1.35e-09 | 157 | 72 | 8 | 30186101 | ||
| Pubmed | NCOA2 KMT2D MYO6 USP9X SMARCA2 CHD7 ARID1A TRIM24 CREBBP MAML3 EP300 RASAL2 | 7.39e-09 | 638 | 72 | 12 | 31182584 | |
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 36464671 | ||
| Pubmed | 1.45e-08 | 78 | 72 | 6 | 28611094 | ||
| Pubmed | Targeting USP9X-AMPK Axis in ARID1A-Deficient Hepatocellular Carcinoma. | 3.01e-08 | 16 | 72 | 4 | 35390516 | |
| Pubmed | CBP/p300 is a cell type-specific modulator of CLOCK/BMAL1-mediated transcription. | 3.40e-08 | 4 | 72 | 3 | 19922678 | |
| Pubmed | 3.40e-08 | 4 | 72 | 3 | 33481850 | ||
| Pubmed | 3.40e-08 | 4 | 72 | 3 | 28398509 | ||
| Pubmed | 3.40e-08 | 4 | 72 | 3 | 31906887 | ||
| Pubmed | 3.40e-08 | 4 | 72 | 3 | 7983737 | ||
| Pubmed | TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation. | 5.05e-08 | 18 | 72 | 4 | 28068325 | |
| Pubmed | 5.05e-08 | 18 | 72 | 4 | 18664271 | ||
| Pubmed | 7.98e-08 | 20 | 72 | 4 | 11877444 | ||
| Pubmed | NCOA2 CACNA1A EBF3 USP9X ENAH SMARCA4 SYN1 GRIA1 CHD7 CAPRIN1 RCOR2 RASAL2 KHSRP | 8.13e-08 | 963 | 72 | 13 | 28671696 | |
| Pubmed | 8.48e-08 | 5 | 72 | 3 | 18487222 | ||
| Pubmed | Structural basis of lysine-acetylated HIV-1 Tat recognition by PCAF bromodomain. | 8.48e-08 | 5 | 72 | 3 | 11931765 | |
| Pubmed | 8.48e-08 | 5 | 72 | 3 | 12200431 | ||
| Pubmed | 8.48e-08 | 5 | 72 | 3 | 19448667 | ||
| Pubmed | FOXJ2 NCOA2 EBF3 CIZ1 SMARCA2 POU2F2 HNRNPUL1 RUNX2 ARID1A TRIM24 CLOCK RCOR2 | 9.77e-08 | 808 | 72 | 12 | 20412781 | |
| Pubmed | 1.27e-07 | 57 | 72 | 5 | 18022353 | ||
| Pubmed | Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor. | 1.35e-07 | 113 | 72 | 6 | 23403292 | |
| Pubmed | 1.69e-07 | 6 | 72 | 3 | 16940996 | ||
| Pubmed | 1.69e-07 | 6 | 72 | 3 | 15731352 | ||
| Pubmed | 1.69e-07 | 6 | 72 | 3 | 15063128 | ||
| Pubmed | 1.69e-07 | 6 | 72 | 3 | 16230384 | ||
| Pubmed | Numerous BAF complex genes are mutated in Coffin-Siris syndrome. | 1.69e-07 | 6 | 72 | 3 | 25081545 | |
| Pubmed | 1.69e-07 | 6 | 72 | 3 | 21933836 | ||
| Pubmed | Coactivation of the CLOCK-BMAL1 complex by CBP mediates resetting of the circadian clock. | 1.69e-07 | 6 | 72 | 3 | 20930143 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 1.78e-07 | 410 | 72 | 9 | 26949251 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | FOXJ2 NCOA2 EBF3 HNRNPUL1 RUNX2 TRIM24 CLOCK CREBBP MAML3 EP300 PYGO1 NCOA5 | 2.35e-07 | 877 | 72 | 12 | 20211142 |
| Pubmed | 2.67e-07 | 66 | 72 | 5 | 23275444 | ||
| Pubmed | 3.24e-07 | 131 | 72 | 6 | 34551306 | ||
| Pubmed | Autism candidate gene DIP2A regulates spine morphogenesis via acetylation of cortactin. | 3.33e-07 | 28 | 72 | 4 | 31600191 | |
| Pubmed | 4.73e-07 | 8 | 72 | 3 | 26986003 | ||
| Pubmed | 4.73e-07 | 8 | 72 | 3 | 10490106 | ||
| Pubmed | 5.09e-07 | 75 | 72 | 5 | 25593309 | ||
| Pubmed | 7.47e-07 | 34 | 72 | 4 | 30894540 | ||
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 8.39e-07 | 154 | 72 | 6 | 16055720 | |
| Pubmed | 1.01e-06 | 10 | 72 | 3 | 12970426 | ||
| Pubmed | Natural helix 9 mutants of PPARγ differently affect its transcriptional activity. | 1.01e-06 | 10 | 72 | 3 | 30595551 | |
| Pubmed | ARID1a-DNA interactions are required for promoter occupancy by SWI/SNF. | 1.01e-06 | 10 | 72 | 3 | 23129809 | |
| Pubmed | 1.01e-06 | 10 | 72 | 3 | 35210568 | ||
| Pubmed | CACNA1A SYN3 MYO6 BCAS3 USP9X SMARCA4 SYN1 GRIA1 ARID1A CAPRIN1 RASAL2 EPN2 KHSRP AGAP3 | 1.19e-06 | 1431 | 72 | 14 | 37142655 | |
| Pubmed | 1.27e-06 | 90 | 72 | 5 | 33087562 | ||
| Pubmed | 1.39e-06 | 11 | 72 | 3 | 31073027 | ||
| Pubmed | Targeting HIV transcription: the quest for a functional cure. | 1.39e-06 | 11 | 72 | 3 | 25731772 | |
| Pubmed | 1.39e-06 | 11 | 72 | 3 | 18003620 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | FOXJ2 NCOA2 KMT2D EBF3 BCAS3 SMARCA4 POU2F2 TRIM24 CREBBP EP300 KHSRP | 1.47e-06 | 857 | 72 | 11 | 25609649 |
| Pubmed | Histone acetyltransferase-dependent chromatin remodeling and the vascular clock. | 1.85e-06 | 12 | 72 | 3 | 14645221 | |
| Pubmed | SPOP targets oncogenic protein ZBTB3 for destruction to suppress endometrial cancer. | 1.85e-06 | 12 | 72 | 3 | 31911863 | |
| Pubmed | 1.85e-06 | 12 | 72 | 3 | 11734557 | ||
| Pubmed | FOXJ2 NCOA2 EBF3 SMARCA2 SMARCA4 POU2F2 ARID1A CREBBP MAML3 PYGO1 | 2.00e-06 | 709 | 72 | 10 | 22988430 | |
| Pubmed | NCOA2 UBQLN2 MYO6 USP9X SMARCA4 HNRNPUL1 R3HDM1 ARID1A CREBBP CAPRIN1 EP300 RASAL2 AGAP3 | 2.10e-06 | 1285 | 72 | 13 | 35914814 | |
| Pubmed | 2.40e-06 | 13 | 72 | 3 | 17340523 | ||
| Pubmed | 2.58e-06 | 46 | 72 | 4 | 20301533 | ||
| Pubmed | AURKA LATS1 USP9X SMARCA2 HIPK2 SMARCA4 ARID1A CREBBP EP300 KHSRP | 2.59e-06 | 730 | 72 | 10 | 34857952 | |
| Pubmed | Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. | 3.05e-06 | 14 | 72 | 3 | 8895581 | |
| Pubmed | Multiplexed molecular interactions of nuclear receptors using fluorescent microspheres. | 3.05e-06 | 14 | 72 | 3 | 11500849 | |
| Pubmed | 3.05e-06 | 14 | 72 | 3 | 12482968 | ||
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 3.50e-06 | 197 | 72 | 6 | 20811636 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 3.51e-06 | 588 | 72 | 9 | 38580884 | |
| Pubmed | 3.80e-06 | 15 | 72 | 3 | 23785148 | ||
| Pubmed | 3.80e-06 | 15 | 72 | 3 | 14701856 | ||
| Pubmed | Mammalian SWI/SNF complexes promote MyoD-mediated muscle differentiation. | 3.80e-06 | 15 | 72 | 3 | 11175787 | |
| Pubmed | Regulation of dendritic development by neuron-specific chromatin remodeling complexes. | 3.80e-06 | 15 | 72 | 3 | 17920018 | |
| Pubmed | Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control. | 3.80e-06 | 15 | 72 | 3 | 17255939 | |
| Pubmed | 3.80e-06 | 15 | 72 | 3 | 17640523 | ||
| Pubmed | 3.80e-06 | 15 | 72 | 3 | 11263494 | ||
| Pubmed | 3.80e-06 | 15 | 72 | 3 | 19762545 | ||
| Pubmed | 4.01e-06 | 446 | 72 | 8 | 24255178 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 27881875 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 8670841 | ||
| Pubmed | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | 4.23e-06 | 2 | 72 | 2 | 34845315 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 19729597 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 23163725 | ||
| Pubmed | Combined gene dosage requirement for SWI/SNF catalytic subunits during early mammalian development. | 4.23e-06 | 2 | 72 | 2 | 23076393 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 15576411 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 39287984 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 15240517 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 26564006 | ||
| Pubmed | SMARCA4/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction. | 4.23e-06 | 2 | 72 | 2 | 33027072 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 23872584 | ||
| Interaction | ERG interactions | NCOA2 KMT2D PYGO2 USP9X SMARCA2 HIPK2 SMARCA4 SYN1 C15orf39 CHD7 HNRNPUL1 ARID1A TRIM24 CREBBP EP300 | 7.51e-16 | 223 | 68 | 15 | int:ERG |
| Interaction | ALG13 interactions | NCOA2 YTHDF1 KMT2D LATS1 TIA1 RBM33 C15orf39 R3HDM2 R3HDM1 ARID1A EP300 YTHDF2 NCOA5 | 3.77e-14 | 183 | 68 | 13 | int:ALG13 |
| Interaction | SOX7 interactions | NCOA2 KMT2D SMARCA2 SMARCA4 C15orf39 CHD7 ARID1A TRIM24 CREBBP EP300 | 1.69e-13 | 82 | 68 | 10 | int:SOX7 |
| Interaction | ETV4 interactions | NCOA2 KMT2D PYGO2 SMARCA2 HNRNPUL1 ARID1A TRIM24 CREBBP EP300 | 1.58e-12 | 69 | 68 | 9 | int:ETV4 |
| Interaction | PAX8 interactions | NCOA2 AURKA KMT2D PYGO2 SMARCA2 CHD7 HNRNPUL1 ARID1A CREBBP EP300 | 3.78e-12 | 111 | 68 | 10 | int:PAX8 |
| Interaction | SP7 interactions | NCOA2 KMT2D PYGO2 RBM33 SMARCA2 SMARCA4 C15orf39 CHD7 ARID1A TRIM24 CREBBP EP300 PYGO1 | 2.42e-11 | 304 | 68 | 13 | int:SP7 |
| Interaction | SMG7 interactions | NCOA2 YTHDF1 KMT2D LATS1 RBM33 R3HDM2 HNRNPUL1 R3HDM1 ARID1A TRIM24 CREBBP CAPRIN1 YTHDF2 | 4.41e-11 | 319 | 68 | 13 | int:SMG7 |
| Interaction | NUP35 interactions | NCOA2 YTHDF1 KMT2D PYGO2 RBM33 SMARCA2 ARID1A TRIM24 TFG CREBBP MAML3 EP300 YTHDF2 NCOA5 | 1.18e-10 | 424 | 68 | 14 | int:NUP35 |
| Interaction | TBXT interactions | 1.88e-10 | 116 | 68 | 9 | int:TBXT | |
| Interaction | LHX4 interactions | NCOA2 KMT2D PYGO2 SMARCA2 SMARCA4 CHD7 HNRNPUL1 ARID1A TRIM24 PYGO1 | 2.11e-10 | 166 | 68 | 10 | int:LHX4 |
| Interaction | EGR2 interactions | NCOA2 KMT2D PYGO2 SMARCA2 C15orf39 CHD7 ARID1A TRIM24 CREBBP EP300 | 2.82e-10 | 171 | 68 | 10 | int:EGR2 |
| Interaction | AR interactions | NCOA2 KMT2D PYGO2 MYO6 RBM33 GRAP2 MED12L SMARCA2 HIPK2 SMARCA4 POU2F2 CHD7 HNRNPUL1 RUNX2 ARID1A TRIM24 CREBBP EP300 KHSRP | 4.04e-10 | 992 | 68 | 19 | int:AR |
| Interaction | EYA4 interactions | FOXJ2 NCOA2 AURKA UBQLN2 RBM33 CIZ1 C15orf39 R3HDM2 R3HDM1 CREBBP EP300 | 5.23e-10 | 243 | 68 | 11 | int:EYA4 |
| Interaction | CRX interactions | NCOA2 KMT2D PYGO2 SMARCA2 C15orf39 CHD7 ARID1A TRIM24 TFG CREBBP EP300 | 8.35e-10 | 254 | 68 | 11 | int:CRX |
| Interaction | SOX9 interactions | 1.25e-09 | 97 | 68 | 8 | int:SOX9 | |
| Interaction | KLF4 interactions | AURKA KMT2D USP9X SMARCA2 SMARCA4 HNRNPUL1 ARID1A CREBBP EP300 | 3.30e-09 | 160 | 68 | 9 | int:KLF4 |
| Interaction | TBR1 interactions | 4.25e-09 | 113 | 68 | 8 | int:TBR1 | |
| Interaction | FUBP3 interactions | YTHDF1 AURKA TIA1 RBM33 R3HDM2 HNRNPUL1 R3HDM1 CAPRIN1 EP300 YTHDF2 KHSRP | 4.31e-09 | 297 | 68 | 11 | int:FUBP3 |
| Interaction | FOS interactions | NCOA2 KMT2D MYO6 SMARCA2 SMARCA4 RUNX2 ARID1A TRIM24 CREBBP EP300 KHSRP | 7.18e-09 | 312 | 68 | 11 | int:FOS |
| Interaction | TLX1 interactions | 7.25e-09 | 175 | 68 | 9 | int:TLX1 | |
| Interaction | ETS1 interactions | 7.31e-09 | 121 | 68 | 8 | int:ETS1 | |
| Interaction | PAX7 interactions | 8.88e-09 | 124 | 68 | 8 | int:PAX7 | |
| Interaction | CREBBP interactions | NCOA2 KMT2D LATS1 PYGO2 SMARCA2 HIPK2 SMARCA4 RUNX2 ARID1A TRIM24 CLOCK CREBBP EP300 YTHDF2 | 1.01e-08 | 599 | 68 | 14 | int:CREBBP |
| Interaction | PAX9 interactions | 1.29e-08 | 130 | 68 | 8 | int:PAX9 | |
| Interaction | YAP1 interactions | KMT2D MRTFB LATS1 UBQLN2 MYO6 USP9X ENAH BUB1B CIZ1 SMARCA2 SMARCA4 HNRNPUL1 RUNX2 ARID1A CREBBP EP300 RCOR2 KHSRP | 1.42e-08 | 1095 | 68 | 18 | int:YAP1 |
| Interaction | WWTR1 interactions | NCOA2 KMT2D LATS1 ENAH SMARCA4 RUNX2 ARID1A CLOCK CREBBP EP300 RCOR2 KHSRP | 1.54e-08 | 422 | 68 | 12 | int:WWTR1 |
| Interaction | GATA2 interactions | KMT2D SMARCA2 SMARCA4 CHD7 ARID1A TRIM24 CYSRT1 CREBBP EP300 | 2.22e-08 | 199 | 68 | 9 | int:GATA2 |
| Interaction | DAZL interactions | 3.04e-08 | 145 | 68 | 8 | int:DAZL | |
| Interaction | CELF1 interactions | YTHDF1 RBM33 CIZ1 R3HDM2 HNRNPUL1 R3HDM1 CAPRIN1 YTHDF2 KHSRP NCOA5 | 4.26e-08 | 288 | 68 | 10 | int:CELF1 |
| Interaction | TLX3 interactions | NCOA2 KMT2D PYGO2 SMARCA2 C15orf39 CHD7 HNRNPUL1 ARID1A TRIM24 EP300 | 4.69e-08 | 291 | 68 | 10 | int:TLX3 |
| Interaction | TLE3 interactions | FOXJ2 NCOA2 KMT2D PYGO2 EBF3 SMARCA4 C15orf39 ARID1A CLOCK CREBBP EP300 | 4.88e-08 | 376 | 68 | 11 | int:TLE3 |
| Interaction | AJUBA interactions | 5.56e-08 | 103 | 68 | 7 | int:AJUBA | |
| Interaction | CEBPA interactions | NCOA2 AURKA KMT2D RBM33 EBF3 SMARCA2 SMARCA4 C15orf39 CHD7 HNRNPUL1 RUNX2 ARID1A TRIM24 CREBBP CAPRIN1 EP300 KHSRP NCOA5 | 1.01e-07 | 1245 | 68 | 18 | int:CEBPA |
| Interaction | GCM1 interactions | 1.09e-07 | 68 | 68 | 6 | int:GCM1 | |
| Interaction | SMAD1 interactions | 1.23e-07 | 243 | 68 | 9 | int:SMAD1 | |
| Interaction | GATA3 interactions | 2.17e-07 | 187 | 68 | 8 | int:GATA3 | |
| Interaction | HNF1B interactions | 2.46e-07 | 190 | 68 | 8 | int:HNF1B | |
| Interaction | MYOD1 interactions | 2.88e-07 | 194 | 68 | 8 | int:MYOD1 | |
| Interaction | HNF4A interactions | 3.51e-07 | 275 | 68 | 9 | int:HNF4A | |
| Interaction | R3HDM1 interactions | 3.89e-07 | 84 | 68 | 6 | int:R3HDM1 | |
| Interaction | FEV interactions | 4.07e-07 | 203 | 68 | 8 | int:FEV | |
| Interaction | IRF4 interactions | 4.18e-07 | 85 | 68 | 6 | int:IRF4 | |
| Interaction | CNOT3 interactions | 4.72e-07 | 207 | 68 | 8 | int:CNOT3 | |
| Interaction | PUM1 interactions | YTHDF1 LATS1 R3HDM2 R3HDM1 TRIM24 CLOCK CAPRIN1 EP300 YTHDF2 | 5.02e-07 | 287 | 68 | 9 | int:PUM1 |
| Interaction | FAM168A interactions | 5.03e-07 | 142 | 68 | 7 | int:FAM168A | |
| Interaction | KLF15 interactions | NCOA2 KMT2D PYGO2 HNRNPUL1 TRIM24 CREBBP CAPRIN1 EP300 YTHDF2 | 5.48e-07 | 290 | 68 | 9 | int:KLF15 |
| Interaction | NR4A1 interactions | 5.65e-07 | 212 | 68 | 8 | int:NR4A1 | |
| Interaction | TDRD3 interactions | 5.65e-07 | 212 | 68 | 8 | int:TDRD3 | |
| Interaction | NCOA1 interactions | 6.07e-07 | 146 | 68 | 7 | int:NCOA1 | |
| Interaction | SMARCC1 interactions | LATS1 SMARCA2 SMARCA4 CHD7 ARID1A CYSRT1 CREBBP CAPRIN1 EP300 KHSRP | 6.10e-07 | 384 | 68 | 10 | int:SMARCC1 |
| Interaction | MKRN2 interactions | FZD1 UBQLN2 MYO6 R3HDM2 CHD7 R3HDM1 CAPRIN1 SDK1 EP300 YTHDF2 | 6.25e-07 | 385 | 68 | 10 | int:MKRN2 |
| Interaction | NR3C1 interactions | FOXJ2 NCOA2 KMT2D MYO6 USP9X SMARCA2 SMARCA4 POU2F2 CHD7 ARID1A TRIM24 CREBBP MAML3 EP300 RASAL2 | 6.59e-07 | 974 | 68 | 15 | int:NR3C1 |
| Interaction | SOX10 interactions | 6.69e-07 | 92 | 68 | 6 | int:SOX10 | |
| Interaction | FOXI1 interactions | 6.69e-07 | 92 | 68 | 6 | int:FOXI1 | |
| Interaction | SOX2 interactions | NCOA2 YTHDF1 KMT2D PYGO2 TIA1 USP9X SMARCA2 SMARCA4 CHD7 RUNX2 ARID1A TRIM24 CLOCK CAPRIN1 EP300 YTHDF2 RCOR2 KHSRP | 7.21e-07 | 1422 | 68 | 18 | int:SOX2 |
| Interaction | EIF4ENIF1 interactions | YTHDF1 TIA1 C15orf39 R3HDM2 R3HDM1 TRIM24 CREBBP CAPRIN1 YTHDF2 | 7.27e-07 | 300 | 68 | 9 | int:EIF4ENIF1 |
| Interaction | SOX17 interactions | 8.09e-07 | 95 | 68 | 6 | int:SOX17 | |
| Interaction | IGF2BP1 interactions | YTHDF1 AURKA LATS1 UBQLN2 R3HDM2 R3HDM1 TRIM24 CAPRIN1 EP300 YTHDF2 KHSRP | 9.81e-07 | 508 | 68 | 11 | int:IGF2BP1 |
| Interaction | SOX6 interactions | 9.91e-07 | 157 | 68 | 7 | int:SOX6 | |
| Interaction | ELF3 interactions | 1.05e-06 | 54 | 68 | 5 | int:ELF3 | |
| Interaction | TPRX2 interactions | 1.26e-06 | 56 | 68 | 5 | int:TPRX2 | |
| Interaction | OTUD4 interactions | 1.27e-06 | 236 | 68 | 8 | int:OTUD4 | |
| Interaction | LHX1 interactions | 1.30e-06 | 103 | 68 | 6 | int:LHX1 | |
| Interaction | KLF8 interactions | NCOA2 KMT2D CHD7 HNRNPUL1 TRIM24 CREBBP CAPRIN1 EP300 YTHDF2 | 1.56e-06 | 329 | 68 | 9 | int:KLF8 |
| Interaction | RXRA interactions | 1.62e-06 | 169 | 68 | 7 | int:RXRA | |
| Interaction | GATA1 interactions | 1.76e-06 | 171 | 68 | 7 | int:GATA1 | |
| Interaction | BMI1 interactions | YTHDF1 TIA1 CIZ1 SMARCA2 SMARCA4 HNRNPUL1 CREBBP CAPRIN1 EP300 YTHDF2 KHSRP NCOA5 | 1.84e-06 | 659 | 68 | 12 | int:BMI1 |
| Interaction | KAT2B interactions | 2.33e-06 | 256 | 68 | 8 | int:KAT2B | |
| Interaction | HELZ interactions | 2.39e-06 | 257 | 68 | 8 | int:HELZ | |
| Interaction | LHX2 interactions | 2.76e-06 | 183 | 68 | 7 | int:LHX2 | |
| Interaction | DZIP3 interactions | 2.76e-06 | 183 | 68 | 7 | int:DZIP3 | |
| Interaction | LHX3 interactions | 2.96e-06 | 185 | 68 | 7 | int:LHX3 | |
| Interaction | PAX6 interactions | 3.73e-06 | 366 | 68 | 9 | int:PAX6 | |
| Interaction | KLF5 interactions | 4.20e-06 | 195 | 68 | 7 | int:KLF5 | |
| Interaction | NANOG interactions | TIA1 USP9X SMARCA2 SMARCA4 CHD7 ARID1A TRIM24 EP300 RCOR2 KHSRP | 4.60e-06 | 481 | 68 | 10 | int:NANOG |
| Interaction | MARF1 interactions | 4.63e-06 | 128 | 68 | 6 | int:MARF1 | |
| Interaction | MYB interactions | 5.77e-06 | 133 | 68 | 6 | int:MYB | |
| Interaction | RBMS1 interactions | 6.21e-06 | 207 | 68 | 7 | int:RBMS1 | |
| Interaction | E2F5 interactions | 6.44e-06 | 36 | 68 | 4 | int:E2F5 | |
| Interaction | HOXB2 interactions | 6.44e-06 | 36 | 68 | 4 | int:HOXB2 | |
| Interaction | BAG2 interactions | NCOA2 MRTFB RBM33 ENAH BUB1B CIZ1 C15orf39 R3HDM1 CREBBP EP300 RASAL2 | 6.88e-06 | 622 | 68 | 11 | int:BAG2 |
| Interaction | TNRC6C interactions | 7.14e-06 | 138 | 68 | 6 | int:TNRC6C | |
| Interaction | KLF1 interactions | 7.20e-06 | 37 | 68 | 4 | int:KLF1 | |
| Interaction | PPARG interactions | 8.85e-06 | 307 | 68 | 8 | int:PPARG | |
| Interaction | IRF1 interactions | 8.92e-06 | 83 | 68 | 5 | int:IRF1 | |
| Interaction | PGR interactions | 9.46e-06 | 84 | 68 | 5 | int:PGR | |
| Interaction | CPEB1 interactions | 9.86e-06 | 146 | 68 | 6 | int:CPEB1 | |
| Interaction | ELF5 interactions | 1.03e-05 | 147 | 68 | 6 | int:ELF5 | |
| Interaction | DDX3X interactions | YTHDF1 MAGEL2 UBQLN2 TIA1 USP9X HNRNPUL1 R3HDM1 CREBBP CAPRIN1 EP300 YTHDF2 | 1.06e-05 | 651 | 68 | 11 | int:DDX3X |
| Interaction | STAT6 interactions | 1.12e-05 | 87 | 68 | 5 | int:STAT6 | |
| Interaction | FOXC1 interactions | 1.17e-05 | 228 | 68 | 7 | int:FOXC1 | |
| Interaction | FMR1 interactions | NCOA2 YTHDF1 TIA1 USP9X SMARCA4 CHD7 R3HDM1 CAPRIN1 YTHDF2 KHSRP | 1.19e-05 | 536 | 68 | 10 | int:FMR1 |
| Interaction | SS18 interactions | 1.19e-05 | 88 | 68 | 5 | int:SS18 | |
| Interaction | PRMT2 interactions | 1.40e-05 | 91 | 68 | 5 | int:PRMT2 | |
| Interaction | CPEB4 interactions | 1.44e-05 | 156 | 68 | 6 | int:CPEB4 | |
| Interaction | SOX5 interactions | 1.78e-05 | 162 | 68 | 6 | int:SOX5 | |
| Interaction | SMAD3 interactions | 1.85e-05 | 447 | 68 | 9 | int:SMAD3 | |
| Interaction | SS18L1 interactions | 2.01e-05 | 98 | 68 | 5 | int:SS18L1 | |
| Interaction | G3BP1 interactions | YTHDF1 AURKA UBQLN2 TIA1 MYO6 HNRNPUL1 R3HDM1 CHCHD2P9 CAPRIN1 EP300 YTHDF2 KHSRP | 2.03e-05 | 835 | 68 | 12 | int:G3BP1 |
| Interaction | PTGDS interactions | 2.06e-05 | 48 | 68 | 4 | int:PTGDS | |
| Cytoband | 7q32-q34 | 2.36e-06 | 2 | 71 | 2 | 7q32-q34 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.47e-08 | 17 | 37 | 4 | 486 | |
| GeneFamily | Synapsins | 1.22e-05 | 3 | 37 | 2 | 1325 | |
| GeneFamily | PHD finger proteins | 3.34e-05 | 90 | 37 | 4 | 88 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 6.11e-04 | 18 | 37 | 2 | 91 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 1.19e-03 | 25 | 37 | 2 | 775 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 5.26e-03 | 53 | 37 | 2 | 532 | |
| GeneFamily | RNA binding motif containing | 9.33e-03 | 213 | 37 | 3 | 725 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.35e-08 | 180 | 64 | 8 | M8239 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NCOA2 AURKA TIA1 USP9X BUB1B SMARCA2 R3HDM2 CERS6 R3HDM1 TRIM24 CLOCK CREBBP | 9.39e-07 | 856 | 64 | 12 | M4500 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CELF6 CACNA1A UBQLN2 SYN3 RBM33 EBF3 GRIA1 ROBO2 POU2F2 CERS6 R3HDM1 RCOR2 RASAL2 | 2.22e-06 | 1106 | 64 | 13 | M39071 |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN | 2.36e-06 | 157 | 64 | 6 | M7733 | |
| Coexpression | PUJANA_BREAST_CANCER_LIT_INT_NETWORK | 4.89e-06 | 101 | 64 | 5 | M15356 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_UP | SYN3 TIA1 ENAH CIZ1 SMARCA4 C15orf39 R3HDM1 TRIM24 SDK1 RCOR2 RASAL2 | 9.43e-06 | 891 | 64 | 11 | M45033 |
| Coexpression | GSE38304_MYC_NEG_VS_POS_GC_BCELL_UP | 9.50e-06 | 200 | 64 | 6 | M9273 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 1.74e-05 | 466 | 64 | 8 | M13522 | |
| Coexpression | GSE45837_WT_VS_GFI1_KO_PDC_UP | 1.16e-04 | 195 | 64 | 5 | M9892 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | 1.18e-04 | 612 | 64 | 8 | M4772 | |
| Coexpression | GSE11864_UNTREATED_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP | 1.24e-04 | 198 | 64 | 5 | M3131 | |
| Coexpression | GSE36009_WT_VS_NLRP10_KO_DC_LPS_STIM_UP | 1.27e-04 | 199 | 64 | 5 | M8769 | |
| Coexpression | GSE411_100MIN_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN | 1.30e-04 | 200 | 64 | 5 | M5995 | |
| Coexpression | GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_UP | 1.30e-04 | 200 | 64 | 5 | M8050 | |
| Coexpression | GSE18893_CTRL_VS_TNF_TREATED_TREG_2H_UP | 1.30e-04 | 200 | 64 | 5 | M7294 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 1.37e-04 | 323 | 64 | 6 | M9150 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML1 | 1.49e-04 | 328 | 64 | 6 | M39064 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | ENAH SYN1 CHD7 HNRNPUL1 ARID1A TRIM24 TFG CLOCK SDK1 MAML3 EP300 EPN2 | 1.52e-07 | 595 | 63 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | NCOA2 MRTFB LATS1 RBM33 USP9X ENAH HIPK2 ROBO2 R3HDM2 CHD7 R3HDM1 MAML3 | 2.64e-06 | 780 | 63 | 12 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.70e-06 | 226 | 63 | 7 | gudmap_developingKidney_e15.5_stage III -IV renal corpusc_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | NCOA2 CACNA1A MRTFB LATS1 SYN3 RBM33 USP9X ENAH SYN1 ROBO2 R3HDM2 CHD7 | 5.06e-06 | 831 | 63 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#1_top-relative-expression-ranked_200 | 7.89e-06 | 92 | 63 | 5 | gudmap_developingGonad_e11.5_testes and mesonephros_k1_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.57e-05 | 379 | 63 | 8 | gudmap_developingKidney_e15.5_1000_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | FOXJ2 TIA1 EBF3 USP9X ENAH MED12L HIPK2 C15orf39 ROBO2 CHD7 CAPRIN1 | 1.97e-05 | 795 | 63 | 11 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | NCOA2 CACNA1A MAGEL2 LATS1 SYN3 ENAH SMARCA4 SYN1 CHD7 MAML3 RASAL2 KHSRP | 2.89e-05 | 989 | 63 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#5_top-relative-expression-ranked_1000 | 8.85e-05 | 152 | 63 | 5 | gudmap_developingKidney_e15.5_S-shaped body_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | TIA1 EBF3 SMARCA4 ROBO2 CHD7 R3HDM1 ARID1A TRIM24 CREBBP RASAL2 | 1.33e-04 | 815 | 63 | 10 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.41e-04 | 385 | 63 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_200 | 1.90e-04 | 179 | 63 | 5 | gudmap_developingGonad_e11.5_testes and mesonephros_200 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_200 | 2.01e-04 | 181 | 63 | 5 | gudmap_developingGonad_e11.5_testes_200 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#5_top-relative-expression-ranked_200 | 2.14e-04 | 99 | 63 | 4 | gudmap_developingGonad_e11.5_testes_k5_200 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | NCOA2 CACNA1A ENAH HIPK2 CHD7 R3HDM1 ARID1A TRIM24 TFG RCOR2 RASAL2 | 2.58e-04 | 1060 | 63 | 11 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.22e-04 | 312 | 63 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#2_top-relative-expression-ranked_500 | 3.41e-04 | 203 | 63 | 5 | gudmap_developingGonad_e11.5_testes_k2_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 4.21e-04 | 328 | 63 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 5.01e-04 | 339 | 63 | 6 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | 5.23e-04 | 629 | 63 | 8 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000 | 5.73e-04 | 979 | 63 | 10 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000 | MAGEL2 MRTFB EBF3 ENAH BUB1B SMARCA4 CHD7 HNRNPUL1 MAML3 KHSRP | 5.92e-04 | 983 | 63 | 10 | Facebase_RNAseq_e9.5_Mandibular Arch_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500 | 6.14e-04 | 231 | 63 | 5 | gudmap_developingGonad_e11.5_testes and mesonephros_k4_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 6.75e-04 | 654 | 63 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.44e-08 | 198 | 64 | 7 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-07 | 179 | 64 | 6 | 479116ac65488c60104a053530830763ec1f95b2 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-07 | 179 | 64 | 6 | 1dfc0cb8b369aef35c59f3d4c52603dc9f3728c1 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-07 | 179 | 64 | 6 | 69a1b3b05c921de6343ffe6ad998aa2b804312a7 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.08e-07 | 198 | 64 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.08e-07 | 198 | 64 | 6 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.20e-07 | 199 | 64 | 6 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 4.33e-07 | 200 | 64 | 6 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Chrm2_(Cerebellum_basket_cells_4)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 5.43e-06 | 80 | 64 | 4 | 54f520cca126810510479fbeade2e3f66fb5dd1b | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Chrm2_(Cerebellum_basket_cells_4)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 5.43e-06 | 80 | 64 | 4 | ce38ea123853a1e1082a033fb779b63ea440661d | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.94e-06 | 179 | 64 | 5 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 6.62e-06 | 183 | 64 | 5 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.16e-06 | 186 | 64 | 5 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.16e-06 | 186 | 64 | 5 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer-27|World / Primary Cells by Cluster | 8.35e-06 | 192 | 64 | 5 | cf989f26c0ebdc0cd12e1e41958f063e4fa3e468 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 8.56e-06 | 193 | 64 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.23e-06 | 196 | 64 | 5 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.69e-06 | 198 | 64 | 5 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.69e-06 | 198 | 64 | 5 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Sigmoid-T_cell-Th17|T_cell / Region, Cell class and subclass | 9.93e-06 | 199 | 64 | 5 | 622f2ae4b1850b25f723a0385da49147dfec8285 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Neuron|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.02e-05 | 200 | 64 | 5 | a581f1704a87b0390e1e2ff85053367d85247755 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D122|Adult / Lineage, Cell type, age group and donor | 6.13e-05 | 148 | 64 | 4 | 81a1e6fdd942a612bf523c59b8b4974f6ca1fdce | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.70e-05 | 157 | 64 | 4 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.70e-05 | 162 | 64 | 4 | 45be019b50e3727fc9d3fad2ff78e74e4f2d746b | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.70e-05 | 162 | 64 | 4 | fbb0cc2b1434a340dc35058b77c73ea61004c252 | |
| ToppCell | BAL-Control-Myeloid-pDC-pDC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.15e-04 | 174 | 64 | 4 | ab654e87c7eab7f33adc61be7a86da5c4d88008d | |
| ToppCell | BAL-Control-Myeloid-pDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.15e-04 | 174 | 64 | 4 | d9bccff5258c4277bdd1edbd87e17c327ec125e8 | |
| ToppCell | BAL-Control-Myeloid-pDC-pDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.15e-04 | 174 | 64 | 4 | 2453419842fd22d066631615403393bfe4449bb8 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic-pDC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.17e-04 | 175 | 64 | 4 | 37c2d4e0b6e9a3171931797ce9a54f3347288e57 | |
| ToppCell | BAL-Control-Myeloid-pDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.17e-04 | 175 | 64 | 4 | 6d5bdfbe53608e01c3845ecd908ca6d0fecc58f8 | |
| ToppCell | BAL-Control-Myeloid-pDC-pDC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.17e-04 | 175 | 64 | 4 | 6839ee3bb4457d13cb08ca8eb79ae33ddd256783 | |
| ToppCell | BAL-Control-Myeloid-pDC-pDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.17e-04 | 175 | 64 | 4 | 9d6135e183179968555670abec39dff9da2c3219 | |
| ToppCell | RA-07._Pericyte|RA / Chamber and Cluster_Paper | 1.33e-04 | 181 | 64 | 4 | 8dfb42d096db6c2df9b41303a7199d134d4bff07 | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-04 | 187 | 64 | 4 | ea9d34bcd3bd1f36745846309ede349773de501a | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.51e-04 | 187 | 64 | 4 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-04 | 187 | 64 | 4 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.54e-04 | 188 | 64 | 4 | ed92cddf47defea2f904d36c7ae05ffa323349a9 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.54e-04 | 188 | 64 | 4 | de6f4889e0c5f39fbbaefd85526f645c6afa09d5 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.57e-04 | 189 | 64 | 4 | 815afad947ed77a8b03724bf78014799fed34f54 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Neuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 1.57e-04 | 189 | 64 | 4 | 3717d1148e26ac78a26aea0ca1dbfbb9d3668877 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-RG-RG-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.61e-04 | 190 | 64 | 4 | 7a560d046aeff979cdf543c519e4e51280f5e232 | |
| ToppCell | 3'_v3-blood-Myeloid_Monocytic-Nonclassical_monocytes|blood / Manually curated celltypes from each tissue | 1.64e-04 | 191 | 64 | 4 | 44a797b39254cbfa5c2bad8155436adfd3019bb0 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-IPC_like|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.64e-04 | 191 | 64 | 4 | 48cffb55c71bb8b34e926fc461fcd345ce43ea00 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-IPC_like-IPCs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.64e-04 | 191 | 64 | 4 | e4c1c533771b582e21683dbec6f93a558d865e00 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.64e-04 | 191 | 64 | 4 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.67e-04 | 192 | 64 | 4 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.67e-04 | 192 | 64 | 4 | 9a2560921b8c0997e1788053004f099439e8f071 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.71e-04 | 193 | 64 | 4 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.71e-04 | 193 | 64 | 4 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.71e-04 | 193 | 64 | 4 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.71e-04 | 193 | 64 | 4 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.71e-04 | 193 | 64 | 4 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 1.71e-04 | 193 | 64 | 4 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.74e-04 | 194 | 64 | 4 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.74e-04 | 194 | 64 | 4 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.74e-04 | 194 | 64 | 4 | 811b382ec3da06a6bda7360abc8b633f96b2019e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.74e-04 | 194 | 64 | 4 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | Control-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 1.74e-04 | 194 | 64 | 4 | 3c2266772c5b56e8e02a461e5193e29588028ee9 | |
| ToppCell | Differ-Basal|World / shred by cell class for mouse tongue | 1.74e-04 | 194 | 64 | 4 | 851eff82c9f3d44c86e3e127a804bbd1fced6a7c | |
| ToppCell | Control-Stromal-Myofibroblast|Control / Disease state, Lineage and Cell class | 1.77e-04 | 195 | 64 | 4 | ffcf76cd72e43d8cf1058a49c76e0956065038bc | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-IPC_like-IPCs/Immature_PNs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.77e-04 | 195 | 64 | 4 | 5e36a881fe2646f5a95d07d7b9265e6ada38730c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 1.77e-04 | 195 | 64 | 4 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.77e-04 | 195 | 64 | 4 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.77e-04 | 195 | 64 | 4 | d70b49f6b9c6c4422adb2936c837a1af7569fb0a | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 195 | 64 | 4 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Control-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 1.77e-04 | 195 | 64 | 4 | 6687e579582d7a239bee80846de0cf827a6f6a62 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 195 | 64 | 4 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.77e-04 | 195 | 64 | 4 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.81e-04 | 196 | 64 | 4 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 196 | 64 | 4 | ef1482f83872af72a55b6c5b5a1491e6f7f44dd7 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.81e-04 | 196 | 64 | 4 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.81e-04 | 196 | 64 | 4 | 760885dc608c82768fe0decd63ed9fda8315f453 | |
| ToppCell | mLN-B_cell-B_cell_cycling|mLN / Region, Cell class and subclass | 1.84e-04 | 197 | 64 | 4 | 806dddcca85c82bd642008d930c8db16b613d88e | |
| ToppCell | mLN-B_cell-B_cell_cycling|B_cell / Region, Cell class and subclass | 1.84e-04 | 197 | 64 | 4 | 2071526fe46de8359ea118ff78581eb4454aa55a | |
| ToppCell | mLN-(2)_B_cell-(24)_B_cell_cycling|mLN / shred on region, Cell_type, and subtype | 1.84e-04 | 197 | 64 | 4 | 70fff2d6723f259e18e7a21d22dc46d71f0759ce | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.84e-04 | 197 | 64 | 4 | 29b0a5927f80455eef7b793feabef69fba1a3df1 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.88e-04 | 198 | 64 | 4 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4|GI_small-bowel / Manually curated celltypes from each tissue | 1.88e-04 | 198 | 64 | 4 | 6333e46cd1ccf5841ce15aea98a4b2f5e3ae4675 | |
| ToppCell | Transverse-T_cell-Th17|T_cell / Region, Cell class and subclass | 1.88e-04 | 198 | 64 | 4 | 918068ffd682c896c11d576072bde270630539d9 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.88e-04 | 198 | 64 | 4 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.88e-04 | 198 | 64 | 4 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.92e-04 | 199 | 64 | 4 | 7b1b3b108d817fb3b50a710c3146b30bcf9c2f6b | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.92e-04 | 199 | 64 | 4 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.92e-04 | 199 | 64 | 4 | f2ad641f36c577ff7019e88ad6b73ed7e46d8c74 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.95e-04 | 200 | 64 | 4 | 780d47f8eff630020dfae32218de495a7e9dbad6 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.95e-04 | 200 | 64 | 4 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.95e-04 | 200 | 64 | 4 | 28dd127787a57276253548d1f030814b1af64481 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 1.95e-04 | 200 | 64 | 4 | ad2a6da0b1ae7a9212a3c91e5eec4baa7481d8dc | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Neuronal-Neuron|1m / Sample Type, Dataset, Time_group, and Cell type. | 1.95e-04 | 200 | 64 | 4 | be1e153119ca4946b4eaef6037e8465f5c00ca6f | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 1.95e-04 | 200 | 64 | 4 | 0350e5ffd36033099b7e32a1fdd790fff99790dc | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Neuron|3m / Sample Type, Dataset, Time_group, and Cell type. | 1.95e-04 | 200 | 64 | 4 | 3d134ae3c48ff4d1849db4fbe44ff73fb6c8c779 | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 3.48e-08 | 177 | 64 | 8 | 7047_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 4.32e-08 | 182 | 64 | 8 | 3887_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.12e-05 | 179 | 64 | 6 | 5822_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.15e-05 | 180 | 64 | 6 | 3688_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 1.15e-05 | 180 | 64 | 6 | 4541_DN | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 1.26e-05 | 183 | 64 | 6 | 7498_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.30e-05 | 184 | 64 | 6 | 2321_DN | |
| Drug | S-2-pentyl-4-pentynoic hydroxamic acid | TIA1 ENAH BUB1B SMARCA2 HIPK2 SYN1 POU2F2 CERS6 ARID1A YTHDF2 NCOA5 | 1.88e-05 | 834 | 64 | 11 | ctd:C513635 |
| Drug | glutamin | 4.36e-05 | 461 | 64 | 8 | CID000000738 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 9.25e-08 | 5 | 63 | 3 | C3281201 | |
| Disease | Sezary Syndrome | 3.19e-07 | 27 | 63 | 4 | C0036920 | |
| Disease | prostate cancer (is_marker_for) | 1.05e-06 | 156 | 63 | 6 | DOID:10283 (is_marker_for) | |
| Disease | Adenoid Cystic Carcinoma | 2.43e-06 | 100 | 63 | 5 | C0010606 | |
| Disease | Coffin-Siris syndrome | 2.61e-06 | 13 | 63 | 3 | C0265338 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 3.83e-06 | 195 | 63 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | Menke-Hennekam syndrome | 4.49e-06 | 2 | 63 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 4.49e-06 | 2 | 63 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 4.49e-06 | 2 | 63 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 4.49e-06 | 2 | 63 | 2 | C4551859 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 4.49e-06 | 2 | 63 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 4.49e-06 | 2 | 63 | 2 | cv:C4551859 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 4.49e-06 | 2 | 63 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | Rubinstein-Taybi Syndrome | 4.49e-06 | 2 | 63 | 2 | C0035934 | |
| Disease | T-Cell Lymphoma | 5.09e-06 | 16 | 63 | 3 | C0079772 | |
| Disease | Small cell carcinoma of lung | 5.51e-06 | 54 | 63 | 4 | C0149925 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.22e-05 | 139 | 63 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | Colorectal cancer | 2.62e-05 | 27 | 63 | 3 | cv:C0346629 | |
| Disease | COLORECTAL CANCER | 2.62e-05 | 27 | 63 | 3 | 114500 | |
| Disease | Neoplasm of the large intestine | 2.62e-05 | 27 | 63 | 3 | cv:C0009404 | |
| Disease | Prostatic Neoplasms | 4.86e-05 | 616 | 63 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 4.86e-05 | 616 | 63 | 8 | C0376358 | |
| Disease | Squamous cell carcinoma of esophagus | 5.19e-05 | 95 | 63 | 4 | C0279626 | |
| Disease | Carcinoma, Transitional Cell | 9.33e-05 | 41 | 63 | 3 | C0007138 | |
| Disease | Embryonal Rhabdomyosarcoma | 1.25e-04 | 8 | 63 | 2 | C0206656 | |
| Disease | colorectal cancer (is_implicated_in) | 1.33e-04 | 121 | 63 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 1.60e-04 | 9 | 63 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | Diffuse Large B-Cell Lymphoma | 2.25e-04 | 55 | 63 | 3 | C0079744 | |
| Disease | Cocaine Dependence | 2.26e-04 | 139 | 63 | 4 | C0600427 | |
| Disease | Bladder Neoplasm | 2.33e-04 | 140 | 63 | 4 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 2.39e-04 | 141 | 63 | 4 | C0005684 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.18e-04 | 152 | 63 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | breast carcinoma (is_marker_for) | 3.86e-04 | 66 | 63 | 3 | DOID:3459 (is_marker_for) | |
| Disease | Sarcoma, Spindle Cell | 4.02e-04 | 14 | 63 | 2 | C0205945 | |
| Disease | Sarcoma, Epithelioid | 4.02e-04 | 14 | 63 | 2 | C0205944 | |
| Disease | Lymphoma, Large-Cell, Follicular | 4.63e-04 | 15 | 63 | 2 | C0079745 | |
| Disease | Lymphoma, Small Cleaved-Cell, Follicular | 4.63e-04 | 15 | 63 | 2 | C0079765 | |
| Disease | Lymphoma, Mixed-Cell, Follicular | 4.63e-04 | 15 | 63 | 2 | C0079758 | |
| Disease | Burkitt Leukemia | 4.63e-04 | 15 | 63 | 2 | C4721444 | |
| Disease | Lymphoma, Follicular, Grade 2 | 4.63e-04 | 15 | 63 | 2 | C1956132 | |
| Disease | Lymphoma, Follicular, Grade 3 | 4.63e-04 | 15 | 63 | 2 | C1956131 | |
| Disease | Lymphoma, Follicular, Grade 1 | 4.63e-04 | 15 | 63 | 2 | C1956130 | |
| Disease | African Burkitt's lymphoma | 4.63e-04 | 15 | 63 | 2 | C0343640 | |
| Disease | neuroticism measurement, wellbeing measurement, depressive symptom measurement | 7.49e-04 | 19 | 63 | 2 | EFO_0007006, EFO_0007660, EFO_0007869 | |
| Disease | Lymphoma, Follicular | 8.32e-04 | 20 | 63 | 2 | C0024301 | |
| Disease | Sarcoma | 9.18e-04 | 21 | 63 | 2 | C1261473 | |
| Disease | disease of metabolism (implicated_via_orthology) | 9.18e-04 | 21 | 63 | 2 | DOID:0014667 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of lung (disorder) | 9.96e-04 | 206 | 63 | 4 | C0152013 | |
| Disease | unipolar depression | 1.00e-03 | 1206 | 63 | 9 | EFO_0003761 | |
| Disease | Ovarian Serous Adenocarcinoma | 1.10e-03 | 23 | 63 | 2 | C1335177 | |
| Disease | Intrahepatic Cholangiocarcinoma | 1.20e-03 | 24 | 63 | 2 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 1.20e-03 | 24 | 63 | 2 | C3805278 | |
| Disease | Cholangiocarcinoma | 1.41e-03 | 26 | 63 | 2 | C0206698 | |
| Disease | triacylglycerol 54:7 measurement | 1.64e-03 | 28 | 63 | 2 | EFO_0010425 | |
| Disease | Cocaine-Related Disorders | 2.03e-03 | 117 | 63 | 3 | C0236736 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| APSQNRGLQNPFPQQ | 251 | O60566 | |
| PQNAASRRTPNNPGN | 1116 | O00555 | |
| PQQQQQLAGGPPQQF | 11 | Q96P47 | |
| FQQPQGVGYPPQQQQ | 2211 | Q09472 | |
| PNQAQSPHLQGQQIP | 2286 | Q09472 | |
| FPCQNPLPVNSGQAQ | 31 | O14965 | |
| PQAQQSRPFPAGAQL | 36 | Q8N9T2 | |
| APIQNQQAWQQPGNP | 76 | A8MQ03 | |
| QAPAQSQFLPQNQFP | 786 | Q92793 | |
| NFTNNNPGNPRLSPL | 506 | Q9H6U6 | |
| NSPPLRAPQSQNGNP | 336 | Q8N7E2 | |
| NHQQPPQQNTGFPRS | 586 | Q14444 | |
| IPGQQHPGQQPSFQQ | 496 | Q9P2D1 | |
| TAFPQQPSALPQQQR | 376 | Q96J87 | |
| LNQPLPQPAQQTGYQ | 671 | Q15032 | |
| AYSPQRGQQLPQPSQ | 541 | Q9Y2K5 | |
| QQGRFLQPRLAPNQP | 471 | Q8IZ40 | |
| FTQPGPAFNQQGQQP | 506 | Q96EV2 | |
| PPAQPQPASQQQAAQ | 1406 | O14497 | |
| QRPGPHFQQQQPLNL | 1026 | Q9H2X6 | |
| LVGQPQQPGFFLQNQ | 1816 | Q86YW9 | |
| RQAQTRPFQQGQPGD | 1896 | Q86YW9 | |
| QPQQPLFPRQGLQQT | 2096 | Q86YW9 | |
| IQLPPQQAQASGPQA | 661 | Q9UJ55 | |
| RQHLQPQRNPYPVQQ | 786 | Q96JK9 | |
| PQRNPYPVQQVNQFQ | 791 | Q96JK9 | |
| PNIPVRSNSFNNPLG | 456 | O95835 | |
| VNPFQVNQPQPLTLN | 551 | O95208 | |
| SQPQQRSQASGNQPP | 471 | Q9HCD5 | |
| QSRNAPLPSLQNGPN | 826 | Q9ULH7 | |
| QPPAQFLLPQAQQSQ | 121 | P09086 | |
| NQPGGLQPLSFQNPV | 771 | Q9UJF2 | |
| QPQQQQAPAQGPSAV | 316 | Q9P0K8 | |
| NFPSQPFNQPLGQNF | 161 | Q9BRQ0 | |
| PPPQQQQSGQQYNGE | 91 | Q9UP38 | |
| QRGQPQAPQQTGAFP | 611 | P87889 | |
| QRGQPQAPQQTGAFP | 611 | Q9YNA8 | |
| QRGQPQAPQQTGAFP | 611 | P62683 | |
| QRGQPQAPQQTGAFP | 611 | P63145 | |
| QRGQPQAPQQTGAFP | 611 | Q7LDI9 | |
| QRGQPQAPQQTGAFP | 611 | P63130 | |
| QRGQPQAPQQTGAFP | 611 | P62685 | |
| QRGQPQAPQQTGAFP | 611 | P63126 | |
| QRGQPQAPQQTGAFP | 611 | P62684 | |
| EPQGTQPAQQQQPCF | 101 | Q5T1J5 | |
| QQQQQLPFHPPGDTA | 491 | O75460 | |
| NPNNDQVFPNGTLAP | 1821 | Q9Y6R7 | |
| ALNIQANGPQIAPPN | 66 | Q6ZMG9 | |
| PRQNSQLPAQVQNGP | 121 | Q8N8S7 | |
| PRNHNQIPTLGNNPA | 416 | Q9H4W6 | |
| FPNNIQIGGLFPNQQ | 21 | P42261 | |
| QYAPAPQQLQQPPQQ | 206 | O75791 | |
| PQQLQQPPQQRYLQH | 211 | O75791 | |
| NPPPQQFINGINQGY | 891 | Q7Z5N4 | |
| GSYNRAPQQQPPPQQ | 686 | Q9BUJ2 | |
| QQPQQPGAPPQQDYT | 631 | Q92945 | |
| FRQNPAENFSQIPPQ | 176 | Q9Y3Y4 | |
| PFNPQGQSQITDPRQ | 276 | Q13950 | |
| RQTSQQPAGPPAQQR | 446 | P17600 | |
| QQPLSPQSGSPQQQR | 466 | O14994 | |
| QGQAPDGQSQPPLQQ | 16 | Q93008 | |
| QQQPALVNYNRPSGP | 251 | P51531 | |
| ALGQQNRGPTPFNQN | 161 | P51532 | |
| NRGPTPFNQNQLHQL | 166 | P51532 | |
| QRGQPQAPQQTGAFP | 611 | P63128 | |
| QQPSQAQLTQPPQQF | 771 | O15516 | |
| QNNVRAVPQPGAFQR | 401 | Q6ZRI6 | |
| QPQVQPQAHSQGPRQ | 376 | Q9ULV3 | |
| PQYSQQQAPPNQTAP | 1021 | Q15596 | |
| QQLRYPPNQNIPRQA | 536 | O15164 | |
| GSNQPTNPNRAQHPE | 36 | Q8NBB2 | |
| GPQQPQQFQGYGQQP | 281 | Q92734 | |
| GSQNLLFPNQPQQPN | 351 | Q9HCK4 | |
| PQPLPNAQSSQAGPN | 266 | Q6S9Z5 | |
| NAPQLPNPEVRFQQQ | 571 | Q9UHD9 | |
| INPVQQQNQIGYPQP | 291 | P31483 | |
| QGSPQPVGQQANNSP | 301 | Q9Y5A9 | |
| ALAQPQYQSPQQPPQ | 311 | Q9BYJ9 | |
| RAPYPGSLPLQQQQQ | 2801 | O14686 | |
| FLNNSPQQNPAAQIP | 1151 | Q9UM54 |